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Purpose: A real-time dose management system was used to determine if radiation exposure 
levels would decrease when providers were privy to their real-time radiation exposure levels. Six 
aggregate categories of providers were first blinded (phase 1) and subsequently made aware of 
their radiation exposure levels during electrophysiology procedures (phase 2). 
Methods: A primary, quantitative crossover study of faculty and staff working in an 
electrophysiology lab at the University of Michigan Hospitals setting occurred. Participants in 
the control group was first blinded in phase 1 to their radiation exposure over an 10-week time 
period. The same group subsequently became the treatment group in phase 2 when over a second 
10-week period real-time exposure levels were made available to them. Power analysis, using a 
40% decrease in exposure, was calculated using a variance of radiation exposure equal to the 
mean radiation exposure with 80% power and alpha = .05. Calculations revealed 102 subjects in 
each treatment and control group were necessary.  
Results: Using the mixed effect linear model, a significant decrease in radiation levels occurred 
in phase 2 as compared to phase 1 for the operator role represented by the combined 
electrophysiologist-fellow role with a P value of .025. Exposure levels in all other provider 
groups for phase 1 or 2 failed to reach statistical significance. All dose values were low and well 
below the US maximum allowable yearly dose of 5,000 mrem per year. 
Conclusion: A real-time radiation dose monitoring system during electrophysiology procedures 
may significantly lower occupational radiation exposure in health care workers. 







The use of ionizing radiation during medical procedures has increased dramatically over 
the past 25 years, putting health care workers potentially at risk for radiation-induced illness.1 In 
1982, the average yearly dose of ionizing radiation from medical exposures was approximately 
0.5 mSv per person in the United States, but by 2006 it had reached 3.0 mSv, representing an 
increase of almost 600%.2 One of the reasons for this rising trend is an increase in minimally 
invasive interventional procedures, defined as diagnostic or therapeutic procedures controlled 
and followed under continuous x-ray (fluoroscopy).3 Although it was originally mostly 
radiologists who performed fluoroscopically guided interventional procedures, today 
cardiologists perform many interventional procedures as well. Interventional cardiac procedures 
account for approximately 12% of all radiological examinations but may deliver substantially 
high radiation dose per procedure.4 “Most experienced (and most exposed) cardiac 
electrophysiologists have an exposure per annum of 5 mSv, 2 to 3 times higher than diagnostic 
radiologists, with a typical cumulative lifetime attributable risk on the order of magnitude of 1 
cancer (fatal and nonfatal) per 100 exposed subjects. The excess cancer risk may involve more 
exposed and less protected organs, such as skin cancer, leukemia, breast cancer in females and 
brain cancer.”5(p79)) As a result of this trend, occupational radiation exposure may be a significant 
concern for cardiac electrophysiologists and support personnel. 
   Advantages of minimally invasive procedures over open surgical procedures are the use 
of a small incision, a substantial reduction in infection rate, and a shorter recovery period. In 
short, it is a better, safer, and more cost-effective way to practice medicine, and it is therefore 
predicted that the high demand for these procedures will continue.6 The disadvantage of 




radiation, depending on the laboratory workload and the complexity of the procedures 
performed.7,8 Radiation exposure to room staff occurs primarily as a result of scattered radiation 
produced from the interaction of the primary radiation beam with the patient and the operating 
table. Medical personnel standing next to a fluoroscopic unit may be exposed to scatter from all 
directions likely striking their upper and lower extremities. Throughout these procedures, 
electrophysiologists and other health care providers are present and delivering patient care. The 
anesthesia provider (AP) assigned to the room is positioned at the head of the bed, in close 
proximity to the radiation source, potentially being exposed to radiation throughout the day when 
providing sedation.  
Radiation is an established level 1 carcinogen, which may target and damage DNA and 
induce cancer-causing mutations.1 It can produce deterministic effects, which are predictable, 
dose related responses with a threshold below which the damage does not occur or stochastic 
effects that are statistically probable effects, not as predictable as deterministic effects. An 
absolute threshold does not exist with stochastic effects, but the incidence is postulated to 
increase with increasing dose. Occupational exposure is generally concerned with stochastic 
effects that result from the chronic and cumulative nature of this type of exposure.   
Damaging effects of radiation can be substantially lessened by adhering to radiation 
safety practices, which are aimed at keeping exposure as low as possible. Minimizing radiation 
exposure is the goal of the radiation safety acronym, ALARA (As Low As Reasonably 
Achievable) that is defined in the Code of Federal Regulations, (NRC 10 CFR 20.1003).9 
Suggested practices for achieving the ALARA goal include proper use of time, distance, and 









 Although ALARA principles are good in theory and offer protective devices and 
precautions to reduce exposure, they are often difficult to fully implement because of the 
required proximity of the provider to the patient, examination complexity, need for maintenance 
of a sterile field, and cramped working conditions. Standard setting committees, such as the 
International Commission on Radiation Protection (ICRP) and the National Council on Radiation 
Protection and Measurements (NCRP), ideally would like to accomplish zero exposure. 
However, realistically, this is not possible if society is to realize the enormous benefits from the 
use of radiation and radioactive materials. Therefore, it is advisable that facilities and equipment 




specific dose standard. However, the problem remains determining what is reasonable given the 
relative risks and benefits to be achieved.11 
Radiation at most institutions is measured by a dosimeter, which is a device worn as a 
badge by personnel during a case involving ionizing radiation, that quantifies exposure produced 
by scatter. Dosimeters currently worn at most institutions are categorized as passive, whole body 
monitors, utilizing optically stimulated luminescence technology. Most institutions use passive 
dosimeters because they are simple, accurate, durable, and reliable. However, they do not offer 
the provider feedback until many weeks/months later after being analyzed at an outside facility. 
At this institution, badges are worn for 3 months before being processed. An additional 7 to 14 
days are necessary as the badges are sent out for evaluation.12 Therefore, a provider at this 
institution will not have radiologic feedback if their badge is elevated for an approximate 3.5-
month timeframe. Radiation safety services notify individual employees if their readings are 
elevated. This methodology does not allow the provider the ability to institute extra precautions 
or change behavior as a result of knowledge of his/her real-time exposure at the point of care. 
Immediately available radiologic information could be very beneficial to providers so they may 
take corrective actions to lessen their exposure during the procedure. 
While patient radiologic exposure has been the subject of attention in the literature, 
personnel exposure is less well studied.13 It is well known that the use of passive personal dose 
meters is associated with noncompliance, which makes quantification of exposure difficult. 
“Failure to wear dosimeters is a problem throughout the world. Lack of compliance with 
radiation badge policies is a problem in many interventional cardiology services.”14(p77) 
Additionally, passive dosimetry does not allow for optimization of radiation protection. One of 




different behaviors affect these levels.15 Therefore, efforts to aid in increasing compliance and 
improving knowledge regarding exposure are indicated. One of the solutions to the issue of 
noncompliance and the need for improvement of radiologic feedback is to increase awareness of 
exposure in real time. Several studies have supported improving awareness with the use of a real-
time dose monitor.13,16,17  
A real-time dose monitoring system represents another option for monitoring radiologic 
scatter and provides immediate feedback regarding radiation exposure on a case-by-case basis. 
Currently, such dosimeters are not intended at present to replace for passive dosimeters, as they 
do not measure effective whole body dose. Real-time dose monitors use digital sensor 
technology, and at present there are no governmental regulations on how to use them. However, 
this may change in the future. Real-time dosimeters allow providers the ability to visualize their 
exposure rate (instantaneous) expressed as uSv per hour, as well as their dose per case or 
cumulative total, expressed as mSv and may increase awareness of their exposure.18 Racadio et 
al, in 2014, concluded that, “A radiation dose monitoring system that provides real-time 
feedback to the interventional staff can significantly reduce radiation exposure to the primary 
operator, most likely by increasing staff compliance with use of radiation protection equipment 
and dose reduction techniques.”19(p119) It is hypothesized that if providers had real-time exposure 
data, they would take more precautions and total exposure levels would decrease. Therefore, the 
research question in this study is: Will the use of a real-time monitoring system result in 
decreased aggregate exposure among faculty and staff working in an electrophysiology lab 
(EPL)? 
If personnel were aware of which tasks lead to elevated radiation exposure, they could 




fellows, who are at constant close proximity to the radiation source, may lower delivered doses 
by altering techniques that minimize elevated exposure associated with cine duration, projection 
angle, pulsed fluoroscopy, and collimation. This awareness could also decrease cumulative total 
radiation received by the patient during the case. Anesthesia providers, RNs, and technicians 
working in the electrophysiology (EP) suite may gauge when to approach the operative field by 
visual cues, maintaining optimal care without compromising the health of the provider. 
Radiologic protective devices such as lead aprons, thyroid shields, and glasses help to attenuate 
exposure but do not provide optimal protection from radiation. Simultaneously minimizing work 
habits that lead to elevated exposure and maximizing compliance while maintaining excellence 
of patient care is mutually achievable. These goals may be facilitated by increased immediate 




REVIEW OF THE LITERATURE 
 Historical Perspectives 
 
Wilhelm Conrad Rontgen is credited with the discovery of x-rays in 1895. Through his 
experimentation with electric current flow using a gas discharge tube, he became aware that 
certain rays were emitted. Crystals of barium platinocyanide, which were scattered on the table, 
began to give off light when the gas discharge tube glowed. Further examination showed that 
wood, paper, aluminum, and some other materials were transparent to these rays. Lead glass was 
permeable to light but not to these rays. He utilized his wife’s hand to look inside the human 
body for the first time. Dr Roentgen was uncertain of the nature of his findings, so he called this 
phenomenon “x-rays” with the “x” indicating the unknown. Doctors quickly learned to use these 
pictures as a diagnostic tool. Dr Rudolf Albert von Kolliker, a colleague, suggested that these 
pictures should be named after the discoverer and so, the Roentgen or x-ray is the name used 
today.20 
The first medical use of x-rays was described in The Lancet on January 23, 1896. The 
report indicated x-rays were utilized diagnostically to locate a piece of knife in the backbone of a 
drunken sailor who was paralyzed until it was surgically removed. This new technology spread 
quickly throughout Europe and the United States. The first therapeutic use of x-rays also 
occurred in 1896 when Leopold Freund, an Austrian surgeon, demonstrated before the Vienna 
Medical society, a hairy mole removal after treatment with x-ray.11 
The same year Antoine Henri Becquerel described radioactivity emitted by uranium 
compounds, and, in 1898, Pierre and Marie Curie isolated the radioactive elements polonium and 
radium.11 The beneficial nature of radiation was realized a few years later when radium was used 




An awareness of the hazardous effects of radiation was also soon recognized in the early 
20th century. Much of the knowledge of the damaging effects of radiation often came at great 
personal loss or death. The first recorded untoward biologic effect of radiation occurred when 
Becquerel described the effects of an accidental contact with radium. He inadvertently left a 
container of radium in his vest pocket. Two weeks later, he described the subsequent skin 
erythema that occurred as well as ulceration that required several weeks to heal.11 It is 
understandable that scientists were unaware of the potential devastating effects of radiation due, 
in part, to the slow onset of symptoms from exposure. Who would suspect an invisible ray, 
similar to light, would be dangerous? Pierre Currie expressed the destructive potential of 
radiation when he theorized radiation could become dangerous in criminal hands and questioned 
whether mankind would benefit from unlocking this “Pandora’s box” of nature. He was 
particularly concerned about the destructive properties of radiation use in war.21 It is tragic that 
Pierre’s fears of the harmful nature of radiation were realized in his own family. His wife, Marie, 
and his daughter, Irene, are both thought to have died from leukemia, induced by prolonged 
exposure to radiation.11 Ultimately the widespread use of radiation resulted in many more 
serious injuries. Therefore, the field of health physics, whose primary focus is the health and 
safety of people working with radioactive materials, was born.21 
 
The Use of Radiation in Medicine  
The existence of radiation has been known for a little over a century. Since its discovery, 
knowledge of its benefits to humans has been weighed against the risk of its potential negative 
effects. Beneficial effects of radiation are utilized in countless places in society; these include 




properties have been utilized in the diagnosis, monitoring, and treatment of a wide variety of 
metabolic processes and disease states. For example, radioactive iodine is used to treat thyroid 
and other cancers. Lives have been saved, life span lengthened, and the quality of life improved 
as a result of the careful application of radiation to the treatment of disease. But, the use of 
radiation is also associated with undesired consequences. These include the potential inducement 
of damage to cellular DNA. Radiation is categorized as a level 1 carcinogen as classified by the 
International Agency for Research of Cancer (IARC).22 The IARC categorizes cancer risk into 4 














Table 2: Standard International Agency for Research on Cancer (IARC) Classification22 
Group 1: "The agent (mixture) is carcinogenic to humans. The exposure circumstance entails 
exposures that are carcinogenic to humans.” “This category is used when there is sufficient 
evidence of carcinogenicity in humans. Exceptionally, an agent (mixture) may be placed in this 
category when evidence of carcinogenicity in humans is less than sufficient but there is 
sufficient evidence of carcinogenicity in experimental animals, and strong evidence in exposed 
humans that the agent (mixture) acts through a relevant mechanism of carcinogenicity.” 
Examples include asbestos, benzene and ionizing radiation.  
Group 2A: "The agent (mixture) is probably carcinogenic to humans.” “The exposure 
circumstance entails exposures that are probably carcinogenic to humans.” “This category is 
used when there is limited evidence of carcinogenicity in humans and sufficient evidence of 
carcinogenicity in experimental animals. In some cases, an agent (mixture) may be classified in 
this category when there is inadequate evidence of carcinogenicity in humans and sufficient 
evidence of carcinogenicity in experimental animals and strong evidence that the 
carcinogenesis is mediated by a mechanism that also operates in humans. Exceptionally, an 
agent, mixture or exposure circumstance may be classified in this category solely on the basis 
of limited evidence of carcinogenicity in humans." Examples include diesel engine exhaust, 
formaldehyde, and PCBs.  
Group 2B: "The agent (mixture) is possibly carcinogenic to humans." "The exposure 
circumstance entails exposures that are possibly carcinogenic to humans. This category is used 
for agents, mixtures and exposure circumstances for which there is limited evidence of 
carcinogenicity in humans and less than sufficient evidence of carcinogenicity in experimental 
animals. It may also be used when there is inadequate evidence of carcinogenicity in humans 
but there is sufficient evidence of carcinogenicity in experimental animals. In some instances, 
an agent, mixture or exposure circumstance for which there is inadequate evidence of 
carcinogenicity in humans but limited evidence of carcinogenicity in experimental animals 
together with supporting evidence from other relevant data may be placed in this 
group." Examples include styrene and gasoline exhaust.  
Group 3: "The agent (mixture) is unclassifiable as to carcinogenicity in humans.” "This 
category is used most commonly for agents, mixtures and exposure circumstances for which the 
evidence of carcinogenicity is inadequate in humans and inadequate or limited in experimental 
animals. Exceptionally, agents (mixtures) for which the evidence of carcinogenicity is 
inadequate in humans but sufficient in experimental animals may be placed in this category 
when there is strong evidence that the mechanism of carcinogenicity in experimental animals 
does not operate in humans. Agents, mixtures and exposure circumstances that do not fall into 
any other group are also placed in this category.” Examples include anthracene, caffeine and 
fluorescent lighting. 
Group 4: "The agent (mixture) is probably not carcinogenic to humans”. “This category is 
used for agents or mixtures for which there is evidence-suggesting lack of carcinogenicity in 
humans and in experimental animals. In some instances, agents or mixtures for which there is 
inadequate evidence of carcinogenicity in humans but evidence suggesting lack of 
carcinogenicity in experimental animals, consistently and strongly supported by a broad range 






Medical procedures using radiation commonly involve the use of x-rays.23 An electrical 
device that accelerates electrons to a high energy and then stops them abruptly in a tungsten or 
gold target produces x-rays outside the molecular nucleus, artificially.11 Some of the kinetic 
energy produced by the electrons is then converted to x-rays.11 When exposed to x-rays, 
photographic film detects shadows that are produced from bones and other structures because 
they are denser than skin. Over time, technologic advances have yielded smaller, lighter, and 
more portable equipment in which higher quality images are produced, but the basic principle of 
capturing images with x-rays remains the same.21  
       The use of medical radiation has steadily increased since the 1980s such that it now nearly 
rivals background radiation. Much of the rapid growth in this trend has occurred from the 
increased use of computed tomography (CT) scans that deliver a great deal more radiation than 
ordinary x-rays.24 Table 3 shows the variation in radiation from tests and procedures and 
indicates CT scans have an effective dose ranging from 10 to 23 mSv.24 CT uses a pencil-thin x-
ray to take multiple images, which are then transferred to a computer where the images are 
displayed in 3D and can be rotated and enlarged on screen. CT is excellent for looking at soft 
tissue, but the radiation exposure can be minimal to high depending on the part of the body being 
studied.25 Many times, patients are excessively scanned because of financial incentives, fear of 
lawsuits, uninformed physicians, misinformed patients, patient demand, and lack of regulation.25 
Because of the high exposure levels produced by CT scans, it is suggested that patients inquire if 
the test is necessary, check the ordering physician’s credentials, ask for the lowest effective dose 
for their size, and avoid unnecessary repeat scans.25 Although CT scans do pose increased 
exposure risk for the patient, medical personnel receive minimal if any occupational radiation 




CT examination is being conducted. 
Table 3: Radiation From Tests/Procedures24 
Sources: American College of Radiology, Health Physics Society, research and review articles  
Test or procedure Effective radiation dose in 
millisieverts (mSv) 
Dental x-ray 0.005 
Chest x-ray 0.02 
Mammogram 0.7 
Coronary calcium scan 1–3 
Background radiation over a year 3 
Abdominal CT 10 




Technetium stress test 6–15 
Thallium stress test 17 
Dual isotope stress test 18–38 
Angiogram 2–23 
Echocardiography  
Magnetic resonance imaging (MRI)  
The sievert reflects the biological effects 







Most radiation exposure to medical personnel occurs as a result of commonly utilized x-
ray procedures. The United Nations Scientific Committee on the Effects of Atomic Radiation 
(UNSCEAR) 2008 report indicated fluoroscopic procedures represent the largest source of 
occupational exposure in medicine.4 “Interventional fluoroscopy procedures are medical 
procedures in which potentially high dose rate x-ray fluoroscopy with high temporal resolution 
may be used to guide navigation, placement or manipulation of medical devices inside the 
human body.”26(p339) Under fluoroscopy, the patient is imaged to guide diagnostic and therapeutic 
procedures, which require medical and technical staff to directly participate.4 So, unlike CT 
procedures, fluoroscopic procedures, which are utilized in the EPL, require that staff is present in 
the room during the entirety of the exam. Therefore, “electrophysiologists and support personnel 
may be exposed to considerable levels of radiation, depending on the laboratory workload and 




Radiation is defined as the emission and propagation of energy through matter or space 
either by means of subatomic particles or by electromagnetic disturbances.11The nucleus of a 
given atom is composed of a certain number of positively charged protons and neutrally charged 
neutrons. This nucleus is surrounded by a rotating cloud of negatively charged electrons, 
identical in number to the protons in this nucleus. As a result, the charges of the electrons and 
protons cancel each other out, producing a neutrally charged atom. Common forms of particle 
radiation include alpha radiation (consisting of a packet of 2 protons and 2 neutrons ejected from 
a nucleus) and beta radiation (consisting of an electron ejected from an atom).11  
Electromagnetic radiation is pure energy, which can be described alternatively as either a 




speed of light. 11Radiation can also be classified as ionizing or nonionizing. Ionizing radiation is 
defined as radiation that has the potential to strip electrons from an atom, therefore producing a 
positively charged, chemically reactive ion from the original atom. Particle radiation can be 
ionizing or nonionizing, depending on whether the particle is traveling fast enough to deliver 
sufficient energy to an atom to cause an electron to exit. Low frequency (and therefore low 
energy electromagnetic radiation) such as electric and magnetic fields, radio waves, microwaves, 
infrared, visible light, and ultraviolet light are examples of non-ionizing radiation. High 
frequency (and therefore high-energy electromagnetic radiation) such as shortwave ultraviolet 
light, x-ray and gamma radiation are examples of ionizing electromagnetic radiation. The 
electromagnetic spectrum is represented in Figure 1.11 
 
 
Figure 1: Illustration of the Electromagnetic Spectrum. X-rays and gamma rays have the 
same nature as visible light, radiant heat, and radio waves; however, they have shorter 
wavelengths, and consequently, larger photon energy. As a result, x-rays and gamma rays can 
break chemical bonds and produce biologic effects.11(p5) 
 
On average, a US resident receives an annual radiation exposure from natural sources of 
about 310 mrem.27 According to a lecture on risk assessment (Donna Livant, PhD, University of 




cosmic radiation, ingested radioactivity, and radiation from the earth’s crust. Cosmic ray 
radiation originates from outside the solar system and from charged particles emanating from the 
sun. It accounts for approximately 26 to 50 mrem per person per year. Ingested radioactivity 
occurs when small traces of radioactive materials are ingested either in food or are inhaled as 
airborne particles. Radioactive thorium, radium, and lead in small quantities can be detected in 
most people. Radioactive potassium-40 represents the largest contributor in food with a dose rate 
of 20 mrem per year. Inhaled radioactivity, primarily radon gas, emanates via seepage through 
the basement of a house from rocks underground. It accounts for approximately 200 mrem per 
year and is the largest contributor to background radiation. Finally, naturally occurring 
radioactive materials in the earth’s crust are widely distributed across the country, and humans 
are exposed to varying gamma rays from them. Quantities vary with the Colorado plateau 
containing more radioactive thorium and uranium registering the highest level at 75 to 140 mrem 
per year. The Northwest, Central and West is intermediate with values of 36 to 75 mrem per year 
and the Atlantic/Gulf Coasts are the lowest at 15 to 35 mrem per year.  
In addition to natural background radiation, the human population is exposed to various 
sources of radiation that result from human activities. Medical radiation is the largest contributor 
to this category. Diagnostic and therapeutic medical procedures such at CT scans, x-rays, and 
nuclear medicine contribute, as previously referenced, an additional 300 mrem per year.2 
Occupational exposures from ionizing radiation represent the final source of annual 
radiation exposure. Scatter radiation represents the primary form of occupational exposure to 
faculty and staff.10 The energy from x-rays is distributed in 3 possible directions upon striking 
internal structures. First, all the energy can be absorbed by a process called the photoelectric 




detector, which produces an image. Third, emitted photons interact with a “free” electron giving 
it a portion of it for kinetic energy. The remaining energy contained in the photons is deflected 
and changed in direction, producing scatter. The Compton effect describes scatter radiation that 
produces hazardous occupational exposure for personnel.(11,28 ) For most individuals in this 
country, occupational exposure represents <0.1% of the total radiologic exposure.11 But, for 
those individuals whose jobs are defined by a consistent daily or weekly exposure to x-rays, this 
value can be considerably higher. 
 
 
Figure 2: Photoelectric Effect: The complete absorption of a photon of x-ray energy by an 
orbital electron. The electron is ejected with a kinetic energy equal to the energy of the incoming 
photon less the binding energy that previously held the electron in orbit. The vacancy is either 






Figure 3: Compton Effect. A photon interacts with a loosely bound electron of an orbital 
electron of the absorbing material. A portion of the photon energy is transferred to the orbital 
electron as kinetic energy. The rest of the energy is reduced in the remaining original photon, 






Radiobiology is defined as the study of the effect of ionizing radiations on living 
organisms.11 Central to understanding the effects of radiation is DNA, a macromolecule that 
carries the genetic material of most organisms and is composed of a sugar phosphate backbone 
and a nitrogenous base.11 It exists as a double stranded helix held together by hydrogen bonds 
between complimentary base pairs. DNA is affected by ionizing radiation resulting in the loss or 
gain of electrons. This reactive process may produce the biological effects of ionization either 
directly or indirectly. The direct effect of radiation is absorption by a target (DNA), which 
comprises approximately one-third of all damage.11 The indirect effect occurs when radiation 
energy is absorbed in nontarget molecules, which then become reactive and subsequently attack 
the target (DNA). The indirect effect is responsible for two-thirds of all damage.11 One of the 




hydroxyl radicals, which are capable of producing damage to DNA. Damage to DNA can 
involve single and double strand breaks, base damage, or interstrand cross-link damage. It may 
also result in damage to molecules that regulate vital cellular processes (RNA, proteins, and 
DNA).11 
Damage to DNA may result in 1 of 3 endpoints: (1) enzymes may be unable to repair the 
damage and the cell dies; (2) enzymes may be able to repair the damaged DNA with no adverse 
effects; or (3) enzymes may inaccurately repair the damaged DNA, resulting in chromosomal 
aberrations, which may result in genetic alterations leading to the production of cancerous 
cells.10 
 Radiation damage is described in terms of its deterministic and stochastic effects. Most 
organs and tissues of the body are unaffected by the loss of a few cells. However, if there is loss 
of a significant portion of cells, observable harm and loss of function may result. Deterministic 
effects are acute in nature, and the severity of the effect in affected individuals varies with the 
threshold dose of exposure. That is, the severity of the effect is dose related.11 An example of a 
deterministic effect is the development of a cataract in irradiated eyes. Most of the information 
regarding deterministic effects of radiation comes from (a) medically exposed groups, (b) the 
survivors of the atomic bombings of Hiroshima and Nagasaki, (c) radiation accidents, and (d) 
animal experiments.29 Stochastic effects describe, “The likelihood or probability of an effect, 
rather than its severity, varies with dose. Disease incidence increases proportionally with dose, 
but there is no dose threshold.”10(p259) Radiation induced carcinogenesis or inherited mutations are 






Radiation Risk Models: Low Dose Exposure 
There is little disagreement regarding the carcinogenic effects of ionizing radiation at 
high doses.1,30 However, the characterization of health effects (cancer and noncancerous) of 
chronic low-dose radiation is controversial. Several studies indicate the adverse effects of 
occupational radiation exposure may, over time, be associated with an increased incidence of 
cataracts, cancers, and possibly other diseases.31 Chronic low-dose exposure occurs in the EP 
area, as almost all procedures require radiation over several hours during any single day. For this 
study, the electrophysiologist and fellow are positioned to the right of the patient, and therefore 
are consistently closest to the radiation source. The anesthesia provider’s workspace is at the 
head of the patient’s bed and the nursing staff is generally situated to the left of the patient.  
  Recent case reports of interventionists with left hemisphere brain malignancies support 
continued safety concerns, since operators typically receive higher levels of ionizing radiation 
exposure to the left side of their bodies.30 Other reports suggest the evidence implicating 
occupational radiation-induced cancer caused by fluoroscopy remains circumstantial and 
inconclusive.31 It’s argued that such studies cannot exclude other biologic agents and chemicals 
unrelated to radiation as being causative.31 For example, a study showed an increased risk for 
brain tumors associated with ionizing radiation, chemical industry, and laboratory work. The use 
of cell phones increased the risk in the most exposed portion of the brain.32 Other case specific 
control studies failed to identify a significant risk of brain tumors caused by exposure to medical 
ionizing radiation.31  
Our understanding of these effects primarily resulted from atomic bomb survivor 
studies.33 Japanese survivors are the single most important group studied because of the large 




of all ages and both sexes received a wide variety of radiation exposures. Approximately 120,000 
people were followed with due vigilance. Fifty thousand incurred doses in excess of 0.005 Sv 
(500 mrem). By 1998, there were more than 17,000 cases of cancer, 853 thought to be caused by 
radiation exposure.11  
Opponents challenge the Japanese survivor data and indicate that this type of exposure 
cannot be compared with medical exposures for several reasons. First, extrapolating health 
effects in the Japanese population to the consequences of low-level exposure to radiation is very 
challenging. The natural incidence of certain types of cancers is very different in the Japanese 
population compared with the United States. For example, breast cancer is approximately 3 times 
higher in the United States, and stomach cancer is 10 times higher in Japan. Second, exposures 
from medical imaging are from x-rays and gamma rays of relatively low energy, many times 
administered intermittently as a consequence of multiple procedures. The atomic blasts exposed 
Japanese residents instantaneously to high-energy gamma rays, neutrons, and charged particles. 
Third, Japanese survivors were exposed to whole-body radiation and to radioactive fallout, 
whereas medical exposures are external irradiation to specified regions of the body. Fourth, it is 
argued that food in Hiroshima and Nagasaki was limited, and much of the population was 
malnourished, which compromised health status. This may have amplified the effects of the 
radiation. Third, the bombs created hazards for this population in addition to the radiation. These 
included high heat and pressure, fire, flying debris, and psychological terror. Because of the 
bomb blasts, the ability to treat the population was hindered, and many people died of injuries 
and exposures that arguably might have survived under better conditions. 34  
  Four radiation risk models have been proposed to assess health risk of exposure to low 




the hypersensitivity model, and the hormesis model (Figure 4). Low dose is defined as 1 to 100 
mSv (100-10,000 mrem) or less than 0.1 mGy per minute over months or a lifetime.35 Of these 4 
models, the LNT is the risk model used internationally by most health agencies and nuclear 
regulators to set dose limits for workers and members of the public.33 
 
  
Figure 4: Radiation Risk Models 
The hypersensitivity model suggests a greater risk at lower doses. 
The LNT model is the straight line that is extrapolated to zero, meaning that cancer risk will rise 
with increasing dose. 
The threshold model implies that below a certain dose, there is no risk. 
The hormesis model suggests that low radiation doses may even be protective and beneficial.33 
 
 




Academy of Sciences Biological Effects of Ionizing Radiation (NAS BEIR) VII as a radiation 
protection risk and is considered the gold standard today, although it is under considerable 
debate. It is the most conservative of the 4 models and says, “Any radiation dose carries with it 
an associated risk of cancer induction, and the risk increases linearly with increasing dose.” 
31(p279),36 The LNT model indicates a straight line that extrapolates to zero, indicating that with 
increasing radiation dose, cancer risk will rise. In absolute terms, interpretation of this theory 
indicates that no amount of radiation should be considered safe, and even the smallest dose (1 
electron hitting a cell) may initiate carcinogenesis. Biochemical evidence indicates, “DNA 
damage resulting from a single ionizing radiation traversal of a cell is expected to be potentially 
different from the biochemical damage resulting from normal oxidative processes.”35(p2) LNT 
postulates that, “It is unlikely that there is a threshold below which cancers are not induced, but 
at low doses, the number of radiation-induced cancers is small.”36 The LNT theory evolved after 
plotting known dose data and incidence of disease using the Japanese bomb survivor data. Where 
data were available, a linear relationship was seen indicating that as radiation dose increased so 
did the incidence of disease. The BEIR VII revealed that the balance of evidence from 
epidemiologic, animal, and mechanistic studies supports a simple, proportionate relationship at 
low doses between radiation dose and cancer risk.35  
As indicated, the LNT model is controversial. Opponents argue this conservative 
approach assumes that cancer incidence, as it relates to radiation dose, behaves in the same way 
as at higher doses; that is, in a linear manner. The theory’s weakness, however, admittedly 
suffers from substantial indetermination in the low dose range. That is, there is little 
epidemiological evidence to substantiate cancer incidence below 100 mSv. For the reasons 




chronic low dose exposure. Scientists have recommended a large-scale study of chronic low dose 
exposure for many years. Currently, a large-scale retrospective epidemiologic study is being 
conducted to support or refute cancer incidence linked to low dose exposure to be discussed later 
in this paper. Proponents argue that extensive efforts were made to compose a highly expert 
committee to avoid conflicts of interest and that the LNT model is based on a comprehensive 
review of the world literature on radiation and epidemiology.  
The threshold model asserts that not all radiation doses are associated with cancer 
induction. In fact, below a certain dose, there is no risk.33 However, after a certain level of 
exposure, cancer risk begins to accumulate. This theory was proposed after cancer incidence and 
mortality data from the atomic bomb survivors were reanalyzed to allow for the possibility of a 
threshold dose. The same dose response models as used in the original papers were used to fit the 
data. The fitted models over predicted the incidence of cancers in the lowest exposure groups. 
This was deemed evidence that a nonlinear rather than a linear threshold model is more 
appropriate.37  
The hypersensitivity model describes a phenomenon in which cells are excessively 
sensitivity to low dose radiation. This model suggests a greater risk of cancer at lower doses of 
radiation and that low dose radiation is more harmful than the LNT because of increased 
sensitivity at a specific point in the cell cycle. A strong association has been shown between low 
dose hyper-radiosensitivity and the survival response of the cells in the G2 phase of the cell 
cycle.38 G2 represents a sensitive phase between DNA syntheses, preceding prophase in 
mitosis.11  
Lastly, the hormesis model proposes a biphasic dose response pattern where low doses 




This model suggests that the risks for cancer risk are smaller than proposed by the LNT model. 
An adaptive response, which produces moderate amounts of stress, can enable the organism to 
perform better. Exposure of individuals to low-dose radiation may elevate the immune response 
thereby protecting individuals from cancer.34(p316) In other words, the view of this model is 
exposure to low dose radiation may promote health.  
 
Radiation Measurement and Risk 
 Dosimeters are radiation detection devices worn by medical providers, which measure 
scatter from ionizing radiation. Dosimeters report effective doses in health care institutions for 
medical workers. The effective dose conveys the fact that some types of radiation are more 
damaging than others, and some parts of the body are more sensitive to radiation than others.11 
Donna Livant, PhD, October 17, 2013, University of Michigan, delivered a lecture on risk 
assessment and conveyed the following key concepts. Effective dose necessitates the 
comprehension of 4 concepts, which are absorbed dose, radiation weighting (WR) factor, 
equivalent dose, and tissue weighting factor (WT). The formula for calculating effective dose is 
expressed as the summation of the absorbed dose times the product of the WR and WT, expressed 
as the following: 
Effective dose = Σ absorbed dose x WR × WT 11(p256) 
 Absorbed dose may be defined as the energy absorbed per unit mass, but absorbed dose 
simply expresses a physical quantity and does not convey the risk of biologic effect. Some 
radiation types are more effective at a certain dose than others. A more appropriate tabulation 
was devised to determine the biological effect of an absorbed dose. It is expressed as: absorbed 




dimensionless multiplier used to assign risks from exposure to different types of radiation on a 
common scale. In essence, it defines the quality of the radiation. For example, the WR for x-rays 
and gamma rays is 1. But the WR for neutrons is 5 to 20, thereby creating the potential for a great 
deal more biologic damage with neutron radiation. The problem with equivalent dosing is that it 
assumes uniformity. If the body was uniformly radiated, the probability of the occurrence of 
stochastic effect is proportional to the equivalent dose, and risk would then be proportional to 
equivalent dose. But, equivalent doses of radiation to different tissues vary substantially, and 
different tissues vary in their sensitivities to radiation-induced stochastic effects.  
 A third more appropriate calculation was devised to account for the tissue-weighting 
factor, WT, which represents the relative contribution of each tissue to the total risk and defines 
effective dose. For example, gonadal tissue and hematopoietic bone marrow have the highest WT 
values at 0.2 and 0.12, respectively, whereas breast, liver, esophagus, bladder, and thyroid have 
WT values of 0.05. Effective dose expresses the sum of all the weighted equivalent doses in all 
the tissues or organs that are irradiated. It is critical because it is proportional to the risk of 
stochastic effects. It measures cancer risk to a whole organism caused by the radiation delivered 
nonuniformly to parts of the body. It best represents risk because it takes into account both the 
type of radiation and the nature of each organ being irradiated. Sieverts (Sv) and rems are the 
units of both equivalent and effective dose.  
Equivalent dose and effective dose cannot be measured directly. Instead, the dose must 
be calculated indirectly from other quantities, which are measured by a personal dosimeter. A 
typical dosimeter contains 2 values denoted personal dose equivalent (Hp) signified Hp (0.07) 
and Hp (10). These values represent the personal dose equivalent in soft tissue at 0.07 and 




worn at the collar and over protective garments, provides a reasonable estimate of the dose 
equivalent in soft tissue delivered to the surface of the unshielded skin and to the lens of the eye. 
In Europe, Hp (10) represents a dosimeter worn on the anterior chest inside leaded garments and 
is an estimate of the operator’s effective dose. However, a single under the lead dosimeter does 
not provide any information regarding eye dose. The formula used to estimate E (effective dose) 
from dosimeter data may be specified by national regulations or by local hospital policy. 
Therefore, in the United States, when a protective apron is worn during procedures using 
fluoroscopy, the NCRP recommends combining the Hp (10) values from both body and collar 
dosimeters to estimate effective dose by the following formula 
E (estimate) = 0.5Hw + 0.025HN39 
where HN is the reading from the dosimeter at the neck, outside the protective apron, and HW is 
the reading from the dosimeter at the waist or on the chest, under the protective apron.39  
 
Personal Dosimeter and Compliance 
  According to the Michigan Department of Licensing and Regulatory Affairs (LARA) , 
radiation safety section rule 222 states: “UM must require the use of assigned dosimetry by 
individuals who are subject to occupational monitoring.”40 As indicated previously, dosimeters 
at many institutions are categorized as passive whole body monitors, utilizing optically 
stimulated luminescence technology. Further, rule 348 states: “Dosimetry must be worn in 
controlled areas by each individual occupationally exposed to ionizing radiation from therapeutic 
or diagnostic x-ray equipment. “Occupationally exposed” means present in a procedure room 





Compliance regarding appropriate wear of dosimeter badges is frequently suboptimal. 
The rate of personal dosimeter use has been reported as less than 50% in the literature.41 
Proposed reasons for lack of compliance are: (1) lack of awareness or immediate feedback from 
the passive dosimeter, (2) improper wearing (placement) of radiation badge, and (3) wearing 
radiation badge inconsistently. Because of the lack of compliance, measurement of radiation 
exposure using a passive dosimeter may be inaccurately reported for any given provider. 
 
Interventionist Data 
Cardiology involves several specialties, 2 of which target minimally invasive 
interventions involving different functionalities of the heart. An electrophysiologist is a 
physician who targets therapy to the electrical conduction system of the heart such as atrial and 
ventricular ablation procedures for arrhythmias. An Interventional cardiologist focus upon 
structural issues of the heart, which cannot be corrected through traditional surgical approaches, 
and alternatively performs procedures such as the stenting of blocked vessels. For the purpose of 
radiation exposure, electrophysiology will be inclusive of considerations for the cardiac 
interventionist. This is because much of the information, which is stated directly regarding 
interventional cardiology, is also true for the electrophysiologist.  
  It is known that “Interventional cardiologists have among the highest radiation 




   
Figure 5: Radiation Exposure Among Various Specialists. The annual radiation exposure of 
different specialists. Interventional cardiologists are by far the most exposed. There is great deal 
of variability between and within procedures. Interventional cardiac procedures include 
diagnostic coronary angiography, percutaneous coronary angioplasty, cardiac ablations, cardiac 
pacemaker, dilation of chronic coronary total occlusion, and endovascular thoracoabdominal 
aneurysm repair.42 
 
 There are several reasons for elevated exposure levels among interventional cardiologists. 
First, the interventionist’s position during the procedure is very close to the x-ray source. 
Second, the interventionist is in close proximity to the patient, which is the scatter source for 
radiation exposure. Third, the intensity of the beam used in this setting lies between radiation 
intensities used in nuclear medicine and radiotherapy.14 
  Shielding also plays a significant role in mitigating radiation exposure but is variable 
because of the duration of the procedure, caseload in the lab, and the relative position of the 
operator, patient, and x-ray source.14 While working in the EP suite, the electrophysiologist may 
alternate their position with the cardiac fellow at the patient’s bedside and in the control room. 




times less than that at the operator’s position.14 When location with respect to shielding is 
considered in addition to the workload of the lab, exposure factors for the interventionist are 
1,000 times higher than those of staff working in the control room.14  
 A variety of personal protective equipment (PPE) and shielding devices are available to 
the electrophysiologist PPE includes a custom fitted lead apron and thyroid shield. Leaded 
moveable shields are also used, but exposure may still be problematic. Other areas of body, the 
head, arms, and legs, remain exposed for prolonged periods (Figure 6).42  
 
 
Figure 6: Dose-Effect Relationship Between Radiation Exposure and Cancer Risk The left 
side of the interventionist is more exposed than the right side in most cases due to the layout of 
the interventional room where the interventionist operates on the right side of the patient. 






Additional radiation-mitigating devices are increasingly being used for protection, which 
include custom fitted goggles, which help to deter cataract formation. The zero gravity system, a 
recent addition to the available PPE, is being used in many EP suites as well. (Figure 7).43  
 
 
                         
Figure 7: Zero Gravity System. The system is a flexible, single, continuous lead barrier, 
suspended from rails and attached to a wheelbase during use. It includes a suit, which allows for 
a greater degree of protection by integrating a body shield with 1-mm lead equivalence and a 





 The system offers greater radiation protection as well as improved comfort when 
compared with traditional shielding. Figure 8 illustrates the zero gravity system has the lowest 




Figure 8: Dose Rate Chart: The exposures to the operator are highly variable depending on the 
radiation protection garments worn. Both the apron and the zero gravity system showed lower 
exposures that the skirt and vest wrap around presumably due to their higher lead equivalencies 
and attenuating properties.44 
 
The zero gravity system provides the best protection, presumably because of its higher 
lead equivalencies and attenuating properties.43 Lead equivalent refers to the thickness of lead 
required to achieve the same shielding against radiation under specified conditions as that 
provided by a given material.45 In this case, the zero gravity system has 1.0 lead equivalencies in 




ranging from .35 to .5.44 The choice of shielding is governed by personal preference, comfort, 
availability, and cost. In the PI’s work environment, 2 zero gravity systems exist for 5 EP suites.  
The 2 most well-known and documented health risks to the interventionists and staff are 
the formation of cataracts and elevated stochastic cancer risk.46 Cataract formation, or 
opacification of the lens, is classified into 3 main categories, nuclear, cortical, and posterior 
subcapsular, according to their anatomic location.42 Posterior subcapsular is the least common 
type but is most frequently associated with ionizing radiation exposure.42 The Retrospective 
Evaluation of Lens Injuries and Dose study (RELID) found that interventionists developed 
posterior subcapsular lens opacities at a 3-fold higher rate than a control group, which didn’t use 
fluoroscopy.30 A French multicenter study also reported a significant increase of posterior 
subcapsular cataract development among interventionists, as did studies in Finland and 
Malaysia.30 Until recently, the dose threshold for radiation-induced cataracts was considered 2 
Gy (200,000 mrem) for a single dose and 5 Gy (500,000 mrem) for fractioned dose.42 However, 
recent epidemiologic findings indicate the dose threshold for cataract formation is 0.5 Gy 
(50,000 mrem).42 After years of exposure without proper protection, occupational exposure can 
potentially exceed 0.5 Gy (50,000 mrem) and is therefore suggested to be a stochastic effect 
exposure.42 It is estimated that cataract formation can be found in up to 50% of interventional 
cardiologists.42 
 Radiation induced malignancy may also be a risk for interventional cardiologists. At the 
molecular level, changes in DNA have shown “interventional cardiologist develop somatic DNA 
damage and chromosomal abnormalities, as measured in vitro by micronuclei frequencies in 
diving peripheral blood cells, at a higher rate than clinical cardiologists.”30 (p225) Several studies 




Table 4: Reports of Brain Cancer Incidence in Physicians, Radiologists, and 
Interventionists  
 
Study Methods Findings 
Matanoski et al, 
197547 
Cohort study of mortality in 6,500 
US male radiologists (years first 
worked, 1920-1969) over a 50-year 
period 
Excess cancer risk among radiologists 
compared with other physicians 
Wang et al, 
199048 
Cohort study of Chinese diagnostic 
x-ray workers (1950-1985) 
Trend of excess cancer risk (standardized 
incidence ratio 1.2 for employment duration 10-
14 years; 2.3 for 15-19 years) compared with 
nonradiation medical workers, not available for 
brain cancer 
Andersson et al, 
199149 
Cohort study of Danish radiation 
therapy workers 
Trend of excess cancer risk (standardized 
incidence ratio 1.09 with measured radiation 
dose < 5 mSv, and 2.23 with dose 5-50 mSv), 
not available for brain cancer 
Carozza et al, 
200050 
Case-control study of occupation and 
glioma 
Physicians at increased, albeit imprecise, risk of 
glioma (OR 3.5, CI 0.7- 17) 
Andersen et al, 
199951 
Population-based study of occupation 
and cancer incidence (from the 1990s 
to 1980s 
Brain cancer increased among physicians in 
general; no breakdown by specialty 
Hardell et al, 
200132 
Case control study of 233 gliomas Excess cancer risk of 6.0 in fluoroscopists 
Blettner et al, 
200752 
Case control study of German 
patients (age 30-59 years at 
diagnosis) with brain cancer in 2001-
2003 
Occupational exposure (physicians, nurses, 
radiographers) with OR 2.49 (0.74-8.38) for 




Report of a case cluster (1990s) Brain cancer in 2 interventionalists  
Roquin et al, 
201254 
Report of 31 brain and neck cancers Tumors included 17 cases (55%) of 
glioblastoma multiforme, 2 astrocytomas (7%), 
and 5 meningiomas (16%). The malignancy was 
left sided in 22 (85%), midline in 1, and right 
sided in 3 operators.  
 





 Over the past century, the trend in radiologic exposure and disease has changed. 
Epidemiological studies of occupational radiation exposure in medicine before 1950 
demonstrated an excess risk of cancer, with increased rates of leukemia, and skin and breast 
malignancies. For example, Matanoski et al conducted a study of mortality in radiologists over a 
50-year period, which showed elevated cancer risk among radiologists compared with other 
physicians (especially for leukemia and lymphoma). The study suggested a possible relationship 
between these finding and immunologic changes induced by radiation.47 Since the mid-20th 
century, average annual occupational radiation dose estimates have decreased 
dramatically.”30(p225) Yet “radiation-induced malignancy remains one of the most feared long-
term occupational risks of fluoroscopy, despite the limited data validating these concerns.”30(p225)  
 Studies focused on brain cancer have emerged. The myth that the brain is radioresistant 
has led many electrophysiologists in past years to fail to protect their heads from ionizing 
radiation. This myth began with the 1906 law of Bergonié and Tribondeau, which states that the 
brain is a highly differentiated organ with low mitotic activity and is therefore radioresistant.42 
However, it is now known that “Ionizing radiation is one of the few established causes of neural 
tumors.”42(p4) A 1991 review of cohort mortality studies among 140,000 white male workers 
exposed to ionizing radiation in the US nuclear programs was studied. The report indicated, “The 
increased risk of brain tumor was highly consistent, persistent and stable, on the order of 
magnitude of 15% to 30%. As a consequence of these data, policy makers have identified brain 
cancer as a “specified” cancer potentially related to occupational exposures under the Energy 
Employees Occupational Illness Compensation Program Act.”42(p4) 
Cardiologists’ annual head exposure (ranging from 20-30 mSv/y) was shown to be 




experienced twice the exposure levels of the right side.56 Physical position of the provider to the 
radiation source is important because the electrophysiologist stands on the right side of the 
patient, but the left side of the cardiologist’s head is closest to the radiation source. A 2013 report 
documented brain and neck tumors in 31 physicians from around the world showing that 23 
interventional cardiologists, 2 electrophysiologists, and 6 interventional radiologists were 
effected. These malignancies were left sided in 22 (85%) of the cases.54 These findings of 
disproportionate left sided tumors suggest the possibility of a causal relationship between brain 
cancer and occupational radiation exposure.54 However, “Epidemiologic evidence of radiation 
induced brain cancer in fluoroscopists is suggestive but by no means conclusive. Essentially, no 
data are available on the contemporary population of invasive fluoroscopists, whose level and 
pattern of head exposure is unprecedented, although some anecdotal clusters of brain cancer have 
been recently described.”42(p4) 
 
Anesthesia Provider  
The Anesthesia provider (AP) delivering sedation or general anesthesia during EP 
procedures may be at risk for increased radiation exposure for several reasons. Ideally, the AP 
remains behind a rolling leaded shield utilizing all radiation protective equipment throughout 
these procedures, but this practice isn’t always possible. He/she frequently may stand very close 
to the patient and the radiologic source, generally 1 to 2 feet away and does not have the 
increased protection at this institution of the leaded skirt at the head of the bed. In many 
radiologic suites a leaded skirt exists attached to the operating room table that partially wraps 
around the bed. Many times it exists only for position of the interventionist to the right of the 




endotracheal tube, the AP must immediately attend to the airway potentially stepping closer to 
the radiation source, increasing exposure. The surgeon may also require an AP to participate or 
intervene during the procedure, placing equipment such as an esophageal stethoscope. 
Anesthetists may also experience increased exposure by association with pharmacologic 
interventions. When a drug is administered, many times the anesthetist steps closer to the 
radiologic source using a port in the IV to administer the medication thereby increasing 
exposure. The interventionist, concentrating on the patient and the procedure at hand, may 
neglect to discontinue use of fluoroscopy while the AP is in harm’s way. Depending on the 
radiation requirements used during this time (cine or projection angle), the AP may experience 
exposure to scatter radiation at high levels.  
  Second, the AP’s daily work habits may increase exposure. Cramped work environments 
are a common occurrence in radiation suites. Since the AP’s primary position is near the head of 
the bed and the workspace is tight, delivering direct patient care while maintaining a safe 
distance from the radiologic source is often impossible. Radiologic emitting devices are large, 
movable pieces of equipment, as is some anesthesia equipment and protective devices such as 
mobile lead screens. Other room staff, such as registered nurses and technicians may also 
experience radiologic exposure because of the need to manage equipment and administer drugs, 
which requires close proximity to the radiation source. However, these providers have the ability 
to use a rolling leaded shield and or retreat to the safety of the control room.  
Very little literature exists on ionizing radiation exposure in APs. Anastasian et al 
compared the forehead radiation exposure of both the anesthesiologist and radiologist during 31 
adult neuroradiology procedures involving head and neck angiography or interventional 




goggles as part of their standardized safety equipment. Anesthesiologists did not. The study 
demonstrated that the scattered radiation exposure to the anesthesiologist’s face could be up to 3 
times that of the radiologist.57 It was not surprising that the radiation level was higher for the 
anesthesiologist than the radiologist, because at the time of this study, the standard of practice for 
radiologists and interventionists was use of leaded eyewear and ceiling-mounted leaded shields 
to protect the face. No such radiologic standard existed for anesthesiologists. It was hypothesized 
that the radiation exposure to the unprotected eye of the anesthesiologists might be in the same 
range as the radiologist. “Exposure to radiologists from scatter radiation during angiography and 
interventional radiologic procedures has been measured and may exceed the threshold for long-
term injury.”57(p513) Multiple linear regression showed that total exposure of the anesthesiologist 
correlated with the number of pharmacologic interventions he was required to make during the 
procedure as well as the total exposure of the radiologist. That is, the total exposure of the 
anesthesiologist was positively correlated with and exceeded the exposure of the radiologist. 
Additionally, giving boluses through the IV also brought the AP closer to the patient’s head and 
therefore closer to the radiation source thereby elevating exposure. Therefore, it was suggested 
anesthesiologists should wear protective eyewear to mitigate eye exposure and ensure parity of 
radiologic protection.  
A prospective study that investigated the level of radiation exposure of anesthetists 
during IR procedures over a 6-month time period in the endoscopic retrograde 
cholangiopancreatography (ERCP) and cardiac catheterization (CC) lab compared the data 
obtained with the current radiation safety guidelines. A total of 1,344 procedures were 
performed. Anesthesia was required for 39/645 in ERCP suite and 86/699 in the CC lab. The 




mrem) for cardiac catheterization. The study, conducted in Pakistan, concluded that anesthetists’ 
exposure rates in this setting were below the allowable maximum level of 20 mSv per year.58 
Radiation exposure of trainee anesthetists working in urology, orthopedics, and radiology 
suites found radiology procedures produced had the highest radiation exposure, followed by 
orthopedics, and then urology. Exposure levels were examined in 732 procedures, 96 (33%) 
orthopedic procedures, 91 (30%) urology procedures, and 50 (39%) radiology procedures. 
Combined net exposure over a 6-month period in urology was 0.2177 mSv (21.77 mrem), 
orthopedics 0.4265 mSv (42.65 mrem), and radiology 3.8457 mSv (384.57 mrem). When 
extrapolated to 1 year, the radiation exposure in this setting was well below the 20 mSv per year 
allowed. The authors suggested that because exposure is low, routine dosimetric monitoring for 
anesthetists is unwarranted.59 
Katz examined radiation exposure of members of a small department of anesthesiology 
(30 anesthesia care providers) by comparing radiation exposure before and after the 
establishment of an EPL. The study was designed to examine the change in radiation exposure to 
the AP after the establishment of an EPL. This was attributed to the proportion of radiation cases, 
which were conducted pre-EPL vs post-EPL. That is, there were 6,337 anesthetic cases with zero 
EP cases before the opening of the EPL. A total of 6,820 anesthetic cases, including 212 EP 
cases post-EPL or after the opening of the EPL, were conducted. The total radiation exposure 
was 503 mrem pre-EPL and 1,006 mrem post-EPL. This data indicated that not only did the 
volume of cases increase in the 6 months postEPL but also with it the opportunity for radiation 
exposure. Even when ALARA principles were practiced, pre-EPL exposure levels were half of 
those seen after the EPL opened. However, in this study, exposure rates were below the US 





Critics argue that is it essentially impossible to accurately predict cancer incidence and 
death in a population of individuals exposed to ionizing radiation at doses below about 100 mSv. 
“No prospective epidemiologic study with non-irradiated control subjects has quantitatively 
demonstrated adverse effects of radiation at doses less than about 100 mSv34(p319) Suspected 
cancer incidence and death from medical imaging procedures lack supporting data and are only 
speculative. A greater ability to accurately predict cancer induction caused by low doses of 
ionizing radiation may be achieved as understanding of the cellular mechanism of cancer 
improve, better criteria for identifying cancer precursors at the cellular and molecular levels are 
developed, and more relevant epidemiologic data on cancer risk of patients exposed to medical 
radiation accumulated in large registries are determined.34  
 Efforts have begun both internationally and nationally to investigate large subpopulations 
of individuals exposed to ionizing radiation. “In 2006, the National Academy of Sciences (BEIR) 
VII committee identified “future occupational radiation studies” as one of the top 10 research 
needs which should include highly exposed populations with a full record of exposure. This 
population is well suited to assessing the effects of long-term, low-level radiation exposure in 
humans.”42(p1) 
The International Nuclear WORKers Study (INWORKS) study was published in Lancet 
Haematology, July 2015.1 The study was designed to strengthen the scientific basis for 
protecting people from low-dose protracted or intermittent radiation exposure. A cohort of 
308,297 radiation-monitored workers employed for at least 1 year in the United States, the 
United Kingdom, and France were monitored by personal dosimeters for external exposure and 




Energy Commission, AREVA nuclear cycle, National Electricity Company in France, 
Departments of Energy and Defense in the United States, and nuclear industry employers 
included in the National Registry for Radiation Workers in the United Kingdom. Doses were 
accrued at very low rates (mean 1.1 mGy [110 mrem, SD 2.6]). The excess relative risk of 
leukemia mortality in these workers (excluding chronic lymphocytic leukemia) was 2.96 per Gy 
(90% CI 1.17-5.21; lagged 2 years), most likely because of an association between radiation dose 
and mortality from chronic myeloid leukemia (relative risk per Gy 10.45, 90% CI 4.48-19.65).1 
The summary stated, “Our results provide direct estimates of risk per unit of protracted dose in 
ranges typical of environmental, diagnostic medical, and occupational exposure.”(pe280) The final 
interpretation indicated, “It provides “strong evidence of an association between protracted low-
dose radiation exposure and leukemia mortality.”1(p276)  
Legislative support for an additional study was garnered when the House of 
Representatives passed Bill HR 5544 on September 18, 2014, which is referred to as the Low 
Dose Radiation Research Act of 2014. HR 5544 mandates: “The Director of the Department of 
Energy shall carry out a research program on low dose radiation. The purpose of the program is 
to enhance the scientific understanding and reduce uncertainties associated with the effects of 
exposure to low dose radiation in order to inform improved risk management methods.”61 The 
bill mandated study coordination with federal agencies. It also imposed an 18-month completion 
time for the study after the date of adoption of the Act.61  
In response to this mandate, the One Million U.S. Radiation Workers and Veterans Study 
is currently in progress. It is an expansive epidemiologic effort coordinated by the NCRP. The 
primary goal of this study is to provide scientifically valid information on the level of radiation 




bomb survivors.62 The primary outcome variable of the study is cancer mortality and is tied to 
the validity of dose reconstruction approaches using a dosimeter badge from Landauer. The 
Million Workers Radiation Study includes a diverse population, 115,000 atomic veterans, 
360,000 US Department of Energy workers, 430,000 nuclear power plant workers, 130,000 
industrial radiographers, and 240,000 medical workers. In assessing medical workers’ exposure, 
an estimated 4 million film-badges and thermoluminescent dosimeter are being examined. It is 
expected the report will be completed in 2016.62  
 
Changing Regulations 
In January 2015, the NCRP announced it is revising radiation regulations. This effort 
would update Report No. 116 and the CC-1 committee was created to aid in this effort.63 The 
CC-1 committee is charged with updating and expanding Report No. 116 on limitation of 
exposure to ionizing radiation.63 New knowledge exists on radiation effects lower than those that 
were apparent in 1993, when the report was published.  
ICRP Report 103, published in 2007, recommended the acceptable effective dose to the 
lens of the eye decrease from 150 mSv (15,000 mrem) to 20 mSV (2,000 mrem) averaged over 5 
years, with no more than 50 mSv (5,000 mrem) in any 1 year.64 The NCRP maintains that the 
goals of radiation protection in the United States are the same as the international community but 
that the degree and approach to obtaining these goals differs. One way the United States differs 
is the allowable maximum of 50 mSv (5,000 mrem) per year limit, which is not in accordance 
with many international limits. According to Scott Pollack, MD, cardiologist at Central Florida 
Cardiology Group, Orlando, Florida, “It is the responsibility of hospitals to protect their 




interventional suites. This action, in conjunction with the possible regulatory changes mandating 
radiation protection, will ensure the safety of physicians and staff.”65 It is therefore suggested 
that ethical and regulatory changes may promote real-time dose monitoring in the future.  
It is clear that a knowledge deficit exists in the measurement of low dose ionizing radiation and 
the stochastic health effects that may be associated with it. The goal of this research is to 
determine if the use of a real-time monitoring system will result in decreased aggregate exposure 
among faculty and staff working in an EPL. This may be accomplished by presumed behavior 
modification including increased use of Personal Protective devices (PPD)’s and incorporation of 
avoidance behaviors but will not be observed as this is beyond the technical feasibility of the 
Primary Investigator (PI) for this study. Evidence-based recommendations from this study will 




RESEARCH QUESTIONS AND HYPOTHESIS 
 
 
1. What is the effect of implementation of real-time dose monitoring on electrophysiologist 
aggregate radiation exposure?  
Hypothesis: It was predicted that aggregate radiation exposure dosage would decrease 
significantly when electrophysiologists were aware of their real-time exposure levels. The 
RaySafe Company touts up to a 40% reduction in physician and staff exposure levels when 
real-time dose monitoring is used.66 Several studies using real-time dose monitoring systems 
have demonstrated a significant decrease in operator dose.19,67,68,69 The University of 
Rochester Medical Center experienced a 50% reduction in staff exposure within the first year 
of implementation of the RaySafe i2 real-time monitoring system.46 
The position of the dose-monitoring screen (base station) is important for replication of 
prior study results. For this study, the base station was positioned in the direct line of vision 
of the operator, where the electrophysiologist or fellow stand. This allowed for visualization 
of the screen for awareness of exposure values (Figure 9). It was predicted that when 
exposure levels were evident, the electrophysiologist would alter his behavior, either by 
taking dose reduction strategies or increasing use of personal protection equipment, although 
observation of these behaviors was not inclusive of this study. One electrophysiologist uses a 
zero gravity system almost exclusively during these procedures. It was expected that this 





























 Figure 9: EP lab 3 and Role Positions.  Indicates shielding used. 
Control indicates control room. Operator indicates the position occupied 
by the interventionist or fellow.  
Indicates radiation source.  
 
 
2. What is the effect of implementation of real-time dose monitoring on cardiac fellow 
aggregate radiation exposure? 
Hypothesis: It was predicted that aggregate cardiac fellow radiation exposure levels would 
decrease significantly in phase 2 after implementation of real-time dose monitoring system. 
The fellow occupies the same physical position as the electrophysiologist during a case, but 
the fellow’s total time in that position varies during a case. The fellow was provided the same 
ability to view the base station and be informed of his/her real-time exposure values. It was 



















3. What is the effect of implementation of real-time dose monitoring on aggregate 
electrophysiologist and cardiac fellow’s combined radiation exposure levels? 
Hypothesis: It was predicted that knowledge of real-time radiation exposure levels would 
result in significantly lower radiation exposure levels for the operator role in phase 2 
represented by the combined electrophysiologist and fellow’s dose. Generally, one of these 
practitioners stands in the operator’s position throughout the procedure. The other alternates 
between the operator’s position and the control room. Combining data from both providers’ 
badges was expected to demonstrate a significant reduction in total exposure after visualizing 
exposure with the real-time monitoring system. 
 
4. What is the effect of implementation of a real-time dose monitoring system on aggregate 
Certified Registered Nurse Anesthetist (CRNA) radiation exposure levels?  
Hypothesis: It was predicted that there would be no significant difference in aggregate 
CRNA radiation exposure levels after implementation of a real-time radiation exposure 
monitoring system in phase 2 resulting from the configuration of the room, which does not 
allow the CRNA to easily see the base station. The base station is positioned at 
approximately a 90° angle from the CRNA, which does not allow for unobstructed viewing. 
The electrophysiologist or cardiac fellow could alert the CRNA of elevated readings and 
when to avoid approaching the patient when periods of high emissions occur during the 
procedure. Prior studies have indicated elevated CRNA exposure. In Mohapatra et al, which 
used a real-time dose monitor in the setting of endovascular procedures, “Findings suggest 





5. What is the effect of implementation of a real-time dose monitoring system on aggregate 
registered nurses circulating in EP lab 3 during cardiac interventional procedures?  
Hypothesis: It was predicted that total exposure levels experienced by registered nurse 
circulators in phase 2 would not change after implementation of real-time dose monitoring. 
The RN workspace is located 180° behind the base station, allowing virtually no opportunity 
for circulating RNs to view the base station.  
 
6. What is the effect of implementation of a real-time dose monitoring system on EP 
technician radiation exposure levels? 
Hypothesis: It was predicted that aggregate exposure levels for EP technicians would not 
change in phase 2 with implementation of real-time dose monitoring. Technicians are 
afforded the opportunity to occupy the protective nature of the control room during a 
procedure, and therefore it was expected their radiation dose would be minimal.  
 
7. What conclusions may be drawn regarding the ability to reduce provider radiation 
exposure levels by increasing knowledge of their exposure levels in real time?  
Hypothesis: If the aggregate dose for any provider type was lower in phase 2 than in phase 1, 
it is suggestive but not conclusive that as providers are made aware of their exposure, they 
were motivated to take protective measures to reduce it. Scott Pollack, MD, cardiologist at 
Central Florida Cardiology Group, Orlando, Florida, stated, “The biggest benefit regarding 
real-time dose monitoring is awareness. Once physicians and staff see their individual 
exposure levels, it becomes personal. Radiation loses its cloak as the silent killer with a 




invasive cardiology services at Good Samaritan Hospital in Lebanon, Pennsylvania, agreed. 
Carver stated, “When physicians and staff are more aware of their personal doses, they are 
more apt to change their behavior.”65  
8. What is the difference in aggregate dose of all providers per procedure type between 
before and after implementation of real-time exposure monitoring?  
Hypothesis: It was expected that there would be a significant difference in total exposure per 
procedure after implementation of a real-time dose monitoring system. Certain procedures are 
associated with considerably more radiation dose than others, most notably ventricular 
tachycardia (V-tach) ablations The difference was expected to be most notable where radiation 

















METHODOLOGY AND DATA COLLECTION 
University of Michigan IRB approval and consent from the Anesthesia Clinical Resource 
Committee were obtained to conduct a quantitative, crossover research study where all subjects 
were assigned to both the treatment and control groups (Appendix 1 and 2). A convenience 
sample of 88 voluntary participants included electrophysiologists, cardiac fellows, nurse 
anesthetists, registered nurses, and technicians who provide care to patients receiving 
interventional EP procedures.   
All subjects were asked to utilize their usual radiation protective equipment. At 
minimum, protective equipment included a leaded apron and thyroid shield (0.05-mm lead 
equivalent). Protective leaded eyewear was also available. A ceiling mounted transparent shield 
and operating room table mounted skirt were available for electrophysiologist and EP fellows. 
The zero gravity system was also available to the electrophysiologist and utilized more 
frequently by a single electrophysiologist. A movable rolling shield was also available, primarily 
used by the nurse anesthetists and registered nurses.  
The study occurred at a University of Michigan hospital in an EPL over a 20-week time 
period and consisted of 2 phases. Six labs exist in the EP area. The director of EP operates 
primarily from EP lab 3 and gave his consent to implement the study in this location. Procedures 
included cardiac ablations, pacemaker implantations, internal cardiac defibrillator insertions, and 
myocardial lead extractions. The real-time display unit remained in a constant fixed position 
attached to the gantry. The gantry is the arm on which all of the monitor screens are mounted for 
viewing radiologic examination data during the procedure. The real-time display was primarily 
directed toward the electrophysiologist and fellow for the duration of the study because of its 




Inclusion criteria consisted of faculty and staff assigned to work in the designated EPL 
during the study period and limited to only those who work solely with adult patients. Eligible 
personnel included Electrophysiologists (n=10), cardiology fellows (n=10), anesthetists (n=95), 
registered nurses (n=20), and technicians (n=15). Providers who do not work in the EPL with the 
adult population and those who declined to participate were excluded. The PI and research 
assistants were not assigned to EP lab 3 for the duration of the study due to the potential for bias. 
No incentives were utilized and providers were asked to sign consent forms to participate in the 
study as part of a standard, nonexempt research project within IRBMED.  
The study utilized the RaySafe i2 system to measure radiation exposure in real time. The 
RaySafe i2 system, shown in Figure 10, contains the following components: 
1. Dosimeter 
2. Real-time display (base station) 
3. Dose viewer (computer software) 
4. Dose manager (computer software) 
5. Dock station (used to connect dosimeters and computer) 






Figure 10: RaySafe i2 Overview: RaySafe i2 System. Dosimeter communicates wirelessly to 
real-time display. Radiation exposure is immediately visualized in real time by logarithmic 
scales in red, yellow and green. Numeric values indicating both instantaneous and accumulated 
values are also visible.66 
 
 
 Dosimeters are worn at the level of the chest on the outside of the lead apron. The device 
measures and records x-ray exposure every second and transfers the data wirelessly to a real-time 






Figure 11: RaySafe i2 Dosimeter. A real time dosimeter worn at the chest level and 
communicates wirelessly to a base station. It provides immediate feedback, shows dose levels 
and enables a provider to avoid dose in real time.66  
 
 
 The real-time display reveals radiation exposure immediately by color indicator bars, 
which may be viewed by all participants in the room (Figure 12). The color indication bars signal 
the intensity of varying levels of exposure in real time. Red signals high exposure (2-20 mSv/h 
or .2-2 rem/h.), yellow signals intermediate (.2-2 mSv/h or .02-.2 rem/h), and green signals low 
level of exposure (<.2 mSv/h or <.02 rem/h).66 Absence of color is ideal and represents zero 
exposure. The accumulated dose is located next to the color indicator bars. By tapping on an 
individual badge, historical information may also be obtained. Up to 8 badges may be viewed 














Figure 12: RaySafe Real-Time Display. It shows real time dose exposure from up to 8 
dosimeters in range at a time. Color indication bars (green, yellow and red) represent the 
intensity of the currently received exposure. The accumulated dose per individual is displayed 
next to the color indication bars. By tapping a dosimeter name the user can look at historical data 
in separtate views.66  
 
 More detailed historical data can be obtained by using the dock station (cradle), which is 
connected to a computer, and viewed using dose viewer and dose manager computer software. 
(Figure 13)66  
 
 
Figure 13: Raysafe Docking Station. The cradle (white outer portion) is a dock station that 
connects a dosimeter to a computer for data read out as well as dosimeter options writing into the 






 The dose viewer is used to assign dosimeters, alter dosimeters names, set colors or reset 
dose history. The dose manager is more complex, involving advanced software and is used to 
analyze and report dose information. It will store and manage dose history from multiple 
dosimeters, collect dose history from real time displays in the hospital network, and analyze dose 
data. Additionally, it will view dose history as a graph or table, export dose data for further 
analysis with other software tools such as excel and create and print report of dose history 
(Figure 14).66  
 
 
Figure 14: RaySafe Dose Manager Function. It is advanced software for analyzing, reporting 
and archiving dose information. It handles multiple dosimeters and can retrieve the dose 





 Participants were also instructed to wear a passive dosimeter that measures cumulative 
exposure over a 3-month period of time. Passive dosimetry is managed by Radiation Safety 
Services and is a requirement for working in any radiologic area at this hospital.40 Data obtained 
from passive dosimeters was not utilized, as these values were not the focus of this study. Both 
dosimeters (passive and real time) measure radiation exposure. However, the passive dosimeters 
measure deep and shallow tissue levels along with lens exposure, reflecting whole body 
exposure. The RaySafe device measures targeted radiation and does not measure whole body 
exposure. These badges are worn at the level of the chest. The RaySafe device is intended to be 
used as an additional piece of equipment to monitor exposure in potentially high dose offsite 
areas such as interventional radiology and EP. It does not, at this time, replace the government 
mandated passive dosimeters.66 In review, real-time monitors are not regulated by the 
government and therefore at present cannot replace passive dosimeters, but this may change in 
the future. Therefore, no attempt was made to measure or estimate either whole body dose or any 
other dose for any individual or group of individuals. Those issues are beyond the technical 
feasibility and scope of the study. This is a study of relative exposures as recorded by the system 
that is sponsoring the investigation.   
In phase 1, which occurred over 10 weeks, the control group, which was blinded, could 
not visualize their radiation exposure readout via their RaySafe dosimeter. The real-time display 
mode was set to the “hide” option in which the dosimeter readings were not shown on the base 
station. During this time, the dosimeter will continue to collect exposure information but were 
not visible to the participants. The dosimeter continued to signal the base station and record 
accumulated dose during this time. During phase 2, the hidden mode was removed, and the same 




Radiation measurement may be expressed in different units. As with distance, weight, 
and temperature, radiation units may be expressed as either SI units (sieverts) or US customary 
units (rem). US scientists and engineers in most fields had converted to the metric system by 
1964 when the National Bureau of Standards officially adopted the International System of 
Units. However, nuclear physicists never officially made this change because even a small error 
in conversion between metric and customary units can be very dangerous. This, in fact, occurred 
with the Mars Climate Orbiter when there was a mistake made in converting these units. Because 
of this concern, the US Nuclear Regulatory Commission still requires plants to report radiation 
releases in rem, while the rest of the world reports in sieverts (Sv).70 The RaySafe device is 
manufactured outside of the United States and therefore reports in sieverts. Measurements in this 
study were reported as millisievert (mSv) and microsievert (uSv). For reference, 1 mSv=100 
mrem=1,000 uSv. 
The independent variable in this study is the provider’s awareness of radiation exposure 
reflected in the factors of phase, generalized procedures, and kerma. The dependent variable is 
dose measured as scatter radiation exposure. Randomization of participants was not utilized 
because there is a specified order of treatment effects. If real-time dose monitoring readouts were 
introduced first, measurements of the blinded control group could have been confounded, and a 
carryover effect could underestimate results during the second phase.  
The RaySafe dosimeter is intended to be a personal dose meter or PDM. That is, each 
badge is identified by a unique code on the back of the badge and is to be linked to 1 person and 
ideally not shared. However, for this study, the RaySafe Company provided 5 badges; for cost 
purposes, all badges were shared in all categories of providers: electrophysiologists, fellows, 




Several practices were utilized to encourage correct usage and compliance with wearing 
the RaySafe badges properly. The night before each data collection day, the PI sent a personal 
email to the CRNA assigned to EP lab 3 for the following day. The study protocol was attached, 
which included instructions on correct placement of the RaySafe badge. The cardiac fellow 
received a text by pager thanking him for participating in the study, as a reminder of having 
consented to participate in the study.  
The RaySafe badge was worn outside the lead apron, attached to the chest pocket with 
the company logo facing outward. At the start of the case, as part of the time-out procedure, the 
CRNA leading the timeout made a statement that both the passive dosimeter as well as the 
RaySafe badges were being worn and appropriately placed for all categories of participants and 
in the correct position on the outside of the lead. The PI, along with research assistants, discussed 
correct badge wear at the time of provider consent. A video illustrating badge wear as well as the 
real-time dose monitoring system was also available at the time consent was obtained 
(https://www.youtube.com/watch?v=KYRVT8GiCQc).71 The PDM was both labeled 
(electrophysiologist, fellow, RN, technician, and anesthetist) and color coded to ensure the 
correct category of participant was wearing each badge daily. For example, the 
electrophysiologist always wore a green PDM; anesthetist, blue; RN, yellow, etc.  
A handoff procedure for badge wear was conveyed to all participants. Handoffs were 
necessary when a relief person arrived during the day. This process was necessary to ensure 
accurate and consistent recording of scatter for each provider group. When handing off a badge, 
anesthetists used a script incorporated into their electronic documentation indicating the 
following: “Sign out/debrief initiated: Please give digital dosimeter for radiation study to relief 




their badges, but the handoff was not documented in the computer when they vacated the room. 
The electrophysiologist and fellow rarely left the EP suite and therefore did not hand off badges 
in a given day. Those choosing not to participate in the study were either assigned to the room or 
were giving breaks in the room and did not wear the badge or their accumulated values were not 
included in the study tabulations. The group primarily affected were the CRNAs, as they had the 
most fluctuation in personnel assigned to the room for breaks and lunches. Thirty-five CRNAs 
were present during the study but not participating as evidenced by Centricity (electronic 
medical record system for anesthesia) sign in and sign out times in the room. Most were 
primarily break personnel and not primary CRNAs assigned to the room for the day. Signs were 
posted on the exit doors and around the EP floor as a reminder to each participant to please hand 
off their badges before exiting the EP suite, and to return the badge at the end of the day. The 
next day began a new collection period. The date changed on the base station and the RaySafe 
dosimeters. A written protocol was also available in all associated providers’ work areas.  
Multiple variables were examined using several electronic systems to obtain the data. 
Variables included were: procedure, total case time/per case and per day, total fluoroscopy 
time/day, total runs/day, total air kerma (mGy)/day, total dose area product (uGym2)/day, 
number of cases/day, aggregate dose/day, individual dose/day, mean dose rate/day, peak dose 
rate/day, number of days of the study, total participants as well as role data (electrophysiologist, 
fellow, anesthetist, RN, and technician) linked to each of these categories. The PI received daily 
automated EP and fellow schedules delivered by Outlook. Outlook is a personal information 
manager from Microsoft utilized by the University for hospital email communication.72 This 
information conveyed the procedure(s) performed, interventionist involved, fellow assigned, and 




each day, the PI was able to tabulate total cases and link individual role identity to the data 
collected.  
The study was designed to measure aggregate data for all roles and only individual values 
where possible because of the limited number of RaySafe badges. Case time data were obtained 
though Centricity, an electronic medical record system used by the anesthesia department. 
Centricity data records events, such as provider in and out times on a second-by-second basis. 
Since radiation is generally not emitted in the room until the procedure begins, the provider in 
and out time interval was utilized as total case time. Total case time also represented the 
aggregate time for the electrophysiologist, fellow, RN, and technician because data were 
reported primarily by group. Since there is 1 interventionist and 1 fellow at the start and end of a 
case, this time period reflected their individual times in the case as well. However, the RN and 
technician were replaced by coworkers for relief periods. These provider substitutions are not 
recorded in the electronic charting system. Therefore, since individual case time could not be 
determined for RNs and technicians, evaluation of their corresponding radiation exposure was 
not possible. Therefore, total aggregate time was determined for all categories collectively 
between phase 1 and 2. Additionally, aggregate data were determined for each of the 6 categories 
along with individual data where possible.  
The CRNA badge also revealed aggregate data like the other badges. However, Raysafe 
did not have a method of determining multiple user radiation readings on a single shared badge. 
Since in this case the PI did have incremental CRNA times for all who entered or exited a case, 
measurement of individual exposure was possible. Additional calculations were necessary to 
determine individual exposure amounts. The CRNA individual case time data were linked to the 




and pivot tables. For example, if CRNA A was present according to Centricity from 9:15:18 to 
09:31:29, the time period was matched to the exact time frame for radiologic exposure on the 
CRNA dosimeter (Figures 15-17). Using these methods, aggregate and individual (CRNAs only) 
exposure data were obtained for faculty and staff. Faculty are defined as the electrophysiologist 
and staff are defined as all other roles.  
 
 
Figure 15: RaySafe Graph-One Day of Exposure−Dose, Peak, and Mean. Highlighted area 
of exposure day of interest. Left side of graft indicates the day’s dose, peak, and mean values for 






Figure 16: RaySafe Dose Table in Dose Manager Application. CRNA daily aggregate data 












Figure 17: Pivot Table Calculations of Individual Doses for CRNAs. Pivot table calculation 
indicates that of the 281 uSv accumulated on this day, 213 were identified with Steve B and 68 







Radiologic data emanating from the x-ray machines were retrieved from the Siemens 
Artis system as well as the EP recording system (EPRS). This allowed for the retrieval of total 
fluoroscopy time, runs, kerma, and DAP per day. Data were stored in Excel on an encrypted 
password protected university owned laptop. The laptop was only used by the PI and only for the 
purposes of this study.  
Staff (RNs, technicians and CRNAs) were assigned to the EPL at the discretion of the 
electrophysiology and anesthesia weekly schedulers. A mirror image of the approximated first 
10-week assignment (control portion) of the study was used for the approximated second 10-
week assignments for the (treatment group) as much as possible. To ensure that everyone who 
volunteered to participate in the study was allowed an opportunity to participate, every effort was 
made by the schedulers to place personnel in EP lab 3 at least twice during the study (1 control 
group and 1 treatment group). The EP float CRNA, who coordinates CRNA breaks and lunches 
to EP lab 3, attempted to assign study participants as much as was feasible. No attempt was made 
to match the procedures each CRNA was assigned to between the 2 phases of the study. This 
would have been technically difficult and could have been misleading because it is not the type 
of procedure, but the complexity of the procedure in an individual patient that determines the 
length of the case and the radiation exposure.  
The recruitment of subjects occurred via a defined protocol. An email, with an IRB 
approved attachment, was sent to potential study participants describing the study and requesting 
voluntary participation (Appendix 3). One follow-up reminder email was sent within 2 weeks of 
the first email announcing locations, dates, and times of the consenting process. Volunteers, who 
wished to participate in the study, were asked to sign consent as part of a standard, nonexempt 




 Consent information was obtained by securing a room at the hospital for the process of 
discussing the project. Individually or by group, time as needed was taken to answer all 
questions and to fully explain the study. If participants wished to meet privately, time would 
have been arranged to meet and discuss the study as well. No inquiries were made for additional 
questioning. Two University of Michigan medical physicists were also available either in person, 
by email, or on call to answer questions regarding the study or other radiation safety related 
questions that potential participants may have at the time of recruitment and consent into the 
study. These individuals were also available to assist with the write up of the study upon 
completion of the data collection to ensure correct interpretation and presentation of radiologic 
parameters. Additionally, a partial waiver of informed consent was requested for the project as 
well. The waiver was necessary for recruitment purposes. The PI assessed patient information 
regarding the procedure in each EPL, which was necessary for recruitment and not for purposes 
of patient care. The PI accessed patient records to determine procedures in each lab to assess 
radiation exposure. Therefore, the PI partially assessed patient information. That is, by IRB 
definition, the PI assessed patient information regarding the procedure in each EPL and radiation 




Statistical analysis was conducted in collaboration with Consulting for Statistics, 
Computing and Analytics Research (CSCAR), at the University of Michigan. Data were 
analyzed using IBM SPSS Statistics V 23.0, and significance was determined at P values <.05. 
The Anderson-Darling was used to assess normality indicated by a P value >.05.73 In this study, 
all parameters of interest had P values <.05, indicating the data were not normally distributed. 
Therefore, the data were reported as medians with lower and upper quartiles (interquartile range 
or IQR).  
 Statistical comparisons used the linear mixed effect model, which is an extension of the 
linear regression model for data and is appropriate for data collected and summarized in 
groups.74 It consists of 2 parts, fixed effects, and random effects. Fixed effects are constant 
across individuals and random effects vary. Fixed effects consist of the conventional linear 
regression portion, which describe the relationship between the dependent variable and one of 
more explanatory independent variables. The dependent variable is the outcome or the effect 
being explained. In this case, the dependent variable, Y, was the dose for each of the 5 
categories. The independent variable is the cause or explanation of the variation associated with 
the dependent variable. For this study, the independent (fixed) factors were phase 1 (blinded) or 
phase 2 (unblinded), generalized procedure, and kerma. Generalized procedures were 
categorized into 1 of 3 procedures, which were atrial fibrillation/atrial flutter ablations, 
ventricular ablations, and device insertions. Kerma was classified as both a fixed effect and a 
covariate as it is a continuous, observed variable. Kerma is the acronym for kinetic energy 
released per unit mass and is reflective of the radiologic output from the equipment used during 
the procedure expressed in m(Gy). Random effects are associated with individual experimental 
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units drawn at random from a population and, in this case, within subject repeated measurement 
occurred. The random variable was participant names associated with each role. Multiple dose 
readings occurred from the same subjects within each group as the EPL is the primary surgical 
setting for cardiac fellows, registered nurses, and technicians with each group representing no 
more than 12 participants. We did observe 1 electrophysiologist who accounts for a large 
proportion of the repeated measurements. Anesthetists didn’t incur as many repeated 
measurements because they represented a larger pool of participants (56) and have a more 
diverse work assignment outside of the EPL. To ensure equitable comparisons between the 
dependent and independent variables, normalization of these parameters was included in the 
formula of the linear mixed effect model as determined by SPSS calculations. 
 Several considerations regarding interpretation of values should be noted regarding the 
linear mixed effect model. The model reports an estimate of fixed effects table for each 
independent variable. The estimate raw or unstandardized regression coefficient is referred to as 
B. It represents the slope or value for the regression equation for predicting the dependent 
variable from the independent variable. When 2 or more correlated predictors exist in the model, 
the B coefficient is known as a partial regression coefficient, and it represents the predicted 
change in the dependent variable when the predictor is increased by 1 unit while holding all other 
predictors constant.75 In this case, the partial regression coefficients were the 3 independent fixed 
factors of phase, generalized procedure, and kerma. For example, a 1-unit increase in kerma is 
predicted to increase dose by 8.68EX.05 for electrophysiologist-fellow with all other 
independent variables held constant (see Table 6, legend). It is important to know that SPSS will 
automatically choose the category with the highest numerical value (or the lowest alphabetical 
letter) as the reference category for categorical variables.76 Phase and generalized procedures are 
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categorical variables and as noted, kerma is a continuous variable. For kerma, the reference or 
starting point for radiation machine output is zero. The reference category is set to zero, and all 
parameters in a category are then compared with the reference of zero. For example, for the fixed 
effect of generalized procedures, V-tach ablations had the highest value and therefore was set to 
zero as the reference value. The other 2 types of procedures of atrial fibrillation/flutter ablations 
and device insertion/revision were then compared with V-tach ablations and values noted.  
The linear mixed effect model used the log total dose as the dependent variable. Kerby 
Shedden, PhD, director of Consulting for Statistics, Computers and Analytics Research 
(CSCAR), in an email on April 24, 2016, indicated that by taking the log of the outcome 
variable, the effect of the predictor variable is expressed in proportional terms. A treatment effect 
may be multiplicative or additive, but it was expected that the effect would be multiplicative in 
this case. Second, the data are quite skewed, and the inferences (P values, etc) for the mixed 
model will be more accurate if the distribution of the dependent variable is roughly symmetric.  
The primary analysis compared preexposure and postexposure, as measured by PDM by 
job title and not by individual. That is, the daily exposures of each of the 5 job titles (groups): 
cardiac electrophysiologist, cardiac fellow, circulator RN, scrub nurse/technician, and CRNA, 
regardless of the individuals working particular days or parts of days was an appropriate fit for 
the linear mixed effect model. In addition, a sixth category was assessed of a combined 
electrophysiologist-fellow role representing the operator position. As indicated previously, at this 
large teaching institution, it is practice that the electrophysiologist and the fellow alternate 
positions between the operator position and the adjacent control room. Both the fellow and the 
electrophysiologist rarely stood in the operator position for any extended time period together. 
To capture all of the radiation that occurred in the operator position, the electrophysiologist and 
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fellow’s doses on their PDMs were summed representing the radiation received in total for the 
operator position. Similarly, kerma could not be assigned proportionately to the 
electrophysiologist or fellow, as the time each person occupied the position was not recorded. 





































A total of 154 procedures were performed during the 4.5-month period from September 
1, 2015 to January 15, 2016. As indicated, the total dose for each participant category was not 
normally distributed as indicated by all P values < 05. An example of this data is provided for 
the operator role (electrophysiologist + fellow doses) in Figures 18 and 19. The entirety of the 
unadjusted descriptive data are summarized in Table 5. Statistically, the values represented in 
Table 5 could not be examined independently. Rather, the fixed and random factors with 
repeated measurement were correlated and could only be assessed by way of the linear mixed 
effect model as represented in Table 6. The results for the electrophysiologist-fellow data 
indicated a significant decrease in exposure with P value = .025 between phase 1 and 2 (Table 
6). This in agreement with the median phase exposure which decreased in phase 1 from 32 uSv 
(IQR 3.0-64.0 uSv, 95% CI, 12.504-48.448) to 7.0 uSv (IQR 1.0-15.0 uSv, 95% CI, 1.0-13.552.) 
in phase 2 (Table 5).  
The other participant categories did not achieve significance for phase. For the CRNA 
data, the primary CRNA in each case was chosen as the main reporting value because that 
provider received the majority of the exposure during the case. Relief CRNAs’ median exposure 
value was 0.0. The primary CRNAs’ median dose in phase 1 was 2.0 uSv (IQR 0-9.5, CI 0-3.16). 
A median of 1.0 mSv (IQR 0.0-5.750, 95% CI 1.0-2.0) was recorded in phase 2. Although the 
CRNA doses were generally low, elevated values were observed in some cases with a maximum 
value of 214.00 uSv for 1 case. RN exposure data showed a median phase 1 value of 1.0 (IQR 
0.00-3.0, CI 0.00-2.0). Phase 2 median value was 1.0 (IQR 0.0-2.0, 95% CI 0.0-2.0).  
 Significance was also obtained for the other 2 variables associated with dose. For the 
CRNA and RN, kerma was significantly associated with dose (P=.00). This is to be expected 
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since as energy per unit mass increases, dose may be expected to increase as well. This positive 
association between kerma and dose was not observed in the electrophysiologist-fellow group in 
which the real-time dose monitor was optimally positioned. A closely related term is the dose 
area product (DAP) that indicates the dose times the exposed area and describes biological 
effect.11 DAP was also collected for each case in this study but could not be included in the 
linear regression due to multicollinearity. A scatterplot of both kerma and DAP are listed in 
Figure 20 indicating kerma and DAP are highly correlated (R=.99; Figure 20).  
 Lastly, generalized procedures achieved significance for the CRNA group with P=.027. 
The implants/revision category within this group had the greatest significance with P=.018. 

























Figure 18: Summary Report for Total Dose-Electrophysiologist and Fellow Team: Phase 1. 
The electrophysiologist-fellow team (operator role) data did not follow a normal distribution in 
phase 1. The median values for the 19 procedures in which both the electrophysiologist and 
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Figure 19: Summary Report for Total Dose-Electrophysiologist and Fellow Team: Phase 2. 
The electrophysiologist-fellow team (operator role) data did not follow a normal distribution in 
phase 2. The median values for the 23 procedures in which both the electrophysiologist and 
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Summary Report for Total Dose - Operator Role
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Table 5: Unadjusted Descriptive Data of Total Case Parameters 
 
Participant data Phase 1 Phase 2 
Operator (Electrophysiologist + 
fellow)     
Total dose (uSv) 1000 388 
Number of procedures 19 23 
Dose mean (uSv) 52.63 16.87 
Dose median (uSv) 32 7 
Dose minimum (uSv) 0 0 
Dose maximum (mSv) 240 131 
CRNA (primary)     
Total dose(uSv) 329 456 
Number of procedures 46 68 
Dose mean (uSv) 7.15 6.7 
Dose median(uSv) 2 1 
Dose minimum (uSv) 0 0 
Dose maximum (mSv) 47 214 
RN     
Total dose(uSv) 107 95 
Number of procedures 50 57 
Dose mean (uSv) 2.14 1.66 
Dose median(uSv) 1 1 
Dose minimum (uSv) 0 0 
Dose maximum (mSv) 19 15 
Total case parameters     
Total procedures 63 91 
Mean kerma (mGY) 519.03 377.71 
Median kerma (mGy) 247 186.5 
Kerma minimum (mGy) 0.1 0 
Kerma maximum (mGy) 3771 2505 
Time in case mean (minutes) 297.51 290.34 
Time in case median (minutes) 229.45 256.75 
Time in case minimum (minutes) 106.92 96.39 






Table 6: Adjusted Data Using Multivariate Linear Mixed Effect Model of Factors 
Associated With Radiation Dose to Electrophysiologist-Fellow, CRNA, and RN  
Parameter Estimate CI P value 
Operator role 
(Electrophysiologist + fellow)       
Phase 1 0.53 (.07, .98) 0.025 
Phase 2 0     
Kerma  0 (-.0003, .0005) 0.665 
Generalized procedure (all)     0.359 
A-fib/flutter -.28 (-.96, .40) 0.413 
Implant/revision -.57 (-1.39, .24) 0.162 
Ventricular tachycardia ablation 0     
CRNA       
Phase 1 -.01 (-.09.07) 0.762 
Phase 2 0     
Kerma (primary CRNA) 0 (.0008, .0012) 0 
Generalized procedure (all)     0.027 
A-fibrillation/flutter -.05 (-.17, .07) 0.407 
Implant/revision -.16 (-.30, -.03) 0.018 
Ventricular tachycardia ablation 0     
RN       
Phase 1 0.05 (-.05, .15) 0.336 
Phase 2 0     
Kerma 0 (.0002, .0004) 0 
Generalized procedure (all)     0.506 
A-fibrillation/flutter -.01 (-.19, .17) 0.919 
Implant/revision -.08 (-.27, .12) 0.444 
Ventricular tachycardia ablation 0     
 
Statistics per IBM SPSS V23.0. Significance determined at P<.05. Phase 2 and ventricular 
tachycardia are the reference categorical variables. Kerma is a continuous variable with reference 
point beginning at 0. Significance noted for phase of the Operator role (electrophysiologist-
fellow) category. The estimate indicates if kerma and generalized procedures are held constant, 
the increase in the outcome variable of dose in phase 1 is .53 more than phase 2. Significance 








Figure 20: The Relationship of DAP and Kerma. Kerma and DAP are highly correlated with 
R2=.9949. To prevent multicollinearity, kerma was the chosen variable in the linear mixed effect 
model.  
 
Several exclusions were made. The data provided evidence that the number of 
technicians wearing their badges was not sufficient to calculate their exposures and therefore 
technician data were excluded. Participants were excluded if they had not signed a consent but 
were assigned to the room and may or may not have worn the study badge.  
 Participants were also excluded from consideration for the day if all 3 values of dose, 
peak, and mean on their PDM indicated radiation exposure was zero. It is possible but unlikely 
that in an 8-hour to16-hour work day ALARA practices may be excellent, or radiation exposure 
may be very low to achieve a zero reading on a badge in all 3 of these categories. It was not 
possible to observe participants during the case to see who was wearing their badge. The PI 
relied solely on feedback retrieved off the badge. Therefore, it was assumed that absence of data 
 83 
for all 3 categories for an entire working day for all cases was considered evidence of 
noncompliance of badge wear among participants. All badges were reviewed for daily use and 
any aggregate badge reading greater than zero in any of the 3 categories was considered to have 
been worn in compliance of the study protocol, as verified by RaySafe representative Chintan 
Shah in phone conversation on April 21, 2016.  
Three cases were excluded due to lack of radiologic examination information pertaining 
to kerma, DAP, runs, and fluoroscopy time. For the CRNAs, 7 days were excluded due to issues 







































In this study, a significant decrease in radiation levels occurred in phase 2 as compared to 
phase 1 for the operator role represented by the combined electrophysiologist/fellow role with 
P=.025. The linear mixed effect model indicates that when generalized procedures and kerma are 
controlled or held constant, there is still a difference between phase 1 and phase 2. It is 
suggestive that this reduction occurred because these participants could directly visualize their 
exposure in real time on the base station in front of them. Because they had continuous and 
immediate feedback, the people in this role likely took more precautions and corrective actions 
during the case, possibly leading to no significance associated with either kerma or generalized 
procedure. Other study participants could not visualize their real-time exposure values as easily, 
and no significant dose reduction occurred associated with phase. It was hoped that those parties 
who could see the exposure monitor would share exposure values with the other providers in the 
room. This instruction was not given as part of the study protocol and did not happen. The nurse 
anesthetist and RN groups did not demonstrate exposure reduction during phase 2.  
The 2 other fixed variables of generalized procedure and kerma had mixed results. 
Significance was obtained for the CRNA groups for kerma with P=0.00. Generalized procedures 
overall were found not significant for either of these groups. However, the CRNA group did 
show partial significance for one of the procedures with P=.018 for implants/revisions although 
overall P=.027 for generalized procedures. As there was no observation of the procedures, the 
rationale for why implants/revisions were significant is unknown at this time. As found in this 
study, certain procedures such as V-tach ablations are associated with greater kerma and thereby 
dose. The higher the output from the radiologic equipment, the higher the dose may be if 
unaware of exposure status. The RNs also had significance of 0.0 for kerma, but generalized 
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procedure was also not significant. So, even though kerma was significant, it was not enough to 
be reflected in dose as a difference between phase 1 and 2 for either role. One explanation is the 
relative position of these providers to the radiation sources, which are the equipment and the 
patient. Figure 9 indicates the relative positions of each provider in the EPL. The RN is further 
away than the CRNA and therefore should not experience as much dose associated with 
procedure. This is because of the inverse square law, which indicates the intensity of the beam is 
inversely related to the square of its distance from the radiation source. So, for example, 
doubling the distance from the source results in one-fourth of the dose.10 Therefore, significance 
for implants/revision procedures amongst the CRNAs was not enough overall to achieve 
significance in dose and reflected as a difference between phase 1 and phase 2.  
The blinded median phase exposure of the interventionist-fellow role of 32 uSv per 
procedure was in keeping with prior demonstrated ranges of .02 to 38.0 uSv per procedure by 
ICRP.14 The wide range in dose was attributed to a wide variation in procedure complexity as 
well as inconsistency in the use of the shield and other personal protective devices.14 The results 
of this study appear to be consistent with these prior observations.  
The results of this study are also consistent with recent studies, which found significantly 
lower operator dose when using a real-time dose monitor. Heilmaier et al found that kerma air 
product (KAP) declined considerably in 15 of 19 types of fluoroscopically guided interventions 
(FGIs) when real-time exposure data were available. They concluded that combined use of a 
patient dose monitoring system and a real-time occupational dose monitoring system in FGIs 
significantly lessens patient and operator exposure doses.67  
A dose aware (DA) real-time monitor was utilized while using the C-arm fluoroscopy 
intraoperatively in a retrospective study by Müller et al.68 The results showed a significant 
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reduction for all evaluated procedure types except for internal fixation of distal radius fractures. 
The conclusion drawn was that use of DA dose monitoring system reduces radiation exposure of 
the orthopedic surgeon and instantly demonstrates the effects of dose-reduction techniques.68  
James et al also found significantly decreased radiation exposure in phase 2 (real-time 
values observed) for all roles except physician A, concluding that real-time dose monitoring 
might help to lower occupational radiation exposure during diagnostic cerebral angiography 
procedures for health care workers.69 Additionally, a similar study conducted in a pediatric 
interventional radiology setting also concluded that a significant reduction in staff operator 
exposure may occur with a real-time dose monitor due to increased staff compliance with the use 
of radiation protection equipment and dose reduction techniques.19   
The Hawthorne effect may have contributed to some reduction in staff dose from the start 
of the study. That is, even though all participants were blinded in phase 1, it is possible that just 
the presence of this new piece of equipment, even though the screen was darkened (blinded), 
may have caused altered behavior. Faculty and staff may have focused the behavior on 
conceived actions that led to altered exposure in phase 1. Vigilance of action in phase 1, although 
blinded, may have led to less difference between the groups in phase 2. Reinforcement of 
presence of the device also occurred by the recruitment and consent documents in which all 
participants were given the opportunity to gain understanding and to answer questions regarding 
the study. However, it is expected the novelty of the device probably wore off fairly quickly and 
so the Hawthorne effect may have had little effect.  
An additional benefit of a real-time dose monitor is a decrease in radiation exposure for 
the patient. Awareness of elevated radiation exposure can lead to actions, which result in lower 
radiation exposure for the patient. The RaySafe Company indicates a 10% reduction of patient 
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dose by using its product.66 “Patients undergoing interventional procedures in cardiology face 
radiation exposure in the order of 1,000 or more times than that involved in conventional 
radiography.”4 (p1) These patients may accrue greater exposure and some patients experience 
several procedures within a relatively short period of time. In addition, patients undergoing EP 
procedures tend to be younger, which is of concern for the stochastic effects of radiation as the 
latency period for inducement of most cancers is 10 years; this is not as great a concern for older 
patients. Counseling is suggested for patients before the procedure if the risk of radiation injury 
is thought to be significant. Important aspects of the patient’s medical history that should be 
considered when estimating radiation risk are genetic factors, coexisting diseases, medication, 
radiation history, and pregnancy.14 Additionally, a medical physicist should be consulted to help 
optimize interventional procedures while minimizing risk.14  
Fluoroscopy systems include multiple variables, which may be adjusted to assist in 
lowering overall exposure. Overall variables to be considered include regulating the amount of 
radiation and image quality are tube voltage (kilovolts), the tube current (milliampere), and pulse 
duration (milliseconds). These settings are autoregulated by the signal received by the detector 
(Figure 20), which is used mainly to compensate for the patient’s weight.77 The operator can 
select different settings for image quality levels. The following are additional considerations for 
reducing radiation exposure.  
1. Cine: Cine involves a series of rapidly recorded multiple images that are taken 
sequentially and displayed on the monitor. The radiation level during this time is 
approximately 10 times higher than during conventional fluoroscopy.78 It is advocated 
that the use of cine should be limited as much as possible and used only when 
necessary.77 
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2. Collimation: A collimator is a device that narrows the beam of particles or waves.79 
Therefore, increasing collimation decreases exposure and scatter. At the beginning of the 
case, a larger view may be more desirable. As the case proceeds and focus is narrowed to 
a particular region, greater collimation is possible and desirable.  
3. Magnification: In order to view an image, a certain amount of radiation is necessary to 
reach each point on the detector. If magnification is increased, then a given amount of 
anatomy is spread out over a larger area of the detector. This would result in less 
radiation per pixel, and the image would be too dark. To correct for this, greater radiation 
is required to improve the clarity of the image. Greater magnification requires greater 
radiation exposure and produces more scatter. When possible, magnification should be 
targeted to the lowest amount.80 
 
 
Figure 21: Beam Direction. Schematic indicating the beam (purple) direction to be received by 
the detector. Most scatter originates from the beam entrance site, which is much closer to the 
operator for procedures from the groin for the LAO tube.77(p952) 
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4. Projection angle: Certain angles of the biplane (fluoroscopy equipment) are associated 
with higher amounts of radiation exposure and scatter than others. During catheter 
ablation procedures, the left anterior oblique (LAQ) angle leads to a 40% to 50% higher 
dose rate for patients than the right anterior oblique projection77 (Figure 21).81 This is 
because the spinal column and more cardiac tissue increase the tube settings. The LAO 
projection, the beam entrance site where most scatter originates is much closer to the 
operator than with the anterior posterior (AP) or the right angle oblique (RAO) 
projections.77 The patient also acts as a poor shield of the entrance site to the operator. 
Radiation near the operator can be 6 times higher with LAO than with RAO.77 In the 
work setting, the anesthesia providers are predominately located at the left side of head of 
the bed, putting them at risk for elevated exposure.  
5. Frame rate: This term refers to the frame frequency and represents the frequency rate at 
which an imaging device displays consecutive images called frames. The greater the 
number of frames, the higher the radiation exposure. When possible, frame rate should be 
reduced.77  
6. Fluoroscopy time: Fluoroscopy time refers to the time in which the beam is on. It should 




Figure 22: Nomenclature for Radiographic Projections. The small black arrowheads show the 
direction of the x-ray beam. Top 3 panels (left to right): right (R) Anterior oblique (AO), 
anterior–posterior, left (L)AO. Middle panel, anterior posterior viewed from patient’s side.  
Bottom left: If the intensifier is tilted toward the head of the patient, a cranial view is produced. 
Bottom right: If the intensifier is tilted toward the feet of the patient, a caudal view is produced. 
(Redrawn from Paulin S. Cathet Cardiovasc Diagn. 1981;7:341-344, and reproduced in Kern MJ 




There were several limitations of the study. First, it was not possible for the PI to make 
any observations of behavior in EP lab 3. This was due primarily to the investigator acting alone 
without additional resources for data retrieval and documentation of all case data. The PI did not 
ask interview participants to learn if they altered their behavior based on the exposure data they 
were seeing. The PI also did not observe the time the electrophysiologist-fellow may have 
overlapped in the operator position. The PI retrieved information at least 1 to 3 times per week to 
ensure the equipment was functioning properly and to retrieve any badges that may have been 
missing due to failure to return them from the day’s use.  
Another limitation was the inability to comment on additional factors, which may have 
increased or decreased exposure. The weight of the patient was not recorded, which is 
contributory to increase exposure as scatter increases with increased mass. Additionally, the 
angle of the biplane was not recorded, which, as previously noted, certain positions such as LAO 
is associated with increased exposure.77 
Additional limitations include issues associated with the equipment. The screen was 
optimally designed for the operator role, and all participants did not have equal viewing ability of 
their exposure. Many participants, such as RNs and CRNAs, could not view their exposure at all 
because of their position in the room. Second, the PDM (badges) from RaySafe are intended to 
be issued to individual participants and not shared and required multiple calculations from the PI, 
which was very time consuming and prone to error. Third, the CRNA badges malfunctioned 
twice requiring replacement and 7 days’ worth of data lost for this category of participant.  
Future suggestions for improvement would be to repeat this study, perhaps as a larger 
pilot study involving additional labs in EP or Interventional radiology. It is further suggested 
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additional staff be allocated to this project to fully observe behavior and interview participants 







































In summary, using the linear mixed effect model, the fixed effect variable phase showed 
a significant decrease in radiation levels in phase 2, as compared with phase 1 for the operator 
position represented by the combined interventionist-fellow role with a P value of .025. Several 
prior studies have demonstrated similar results when participants are aware of their 
exposure.19,67,68,69 Lower exposure may decrease the risk of the stochastic effects of protracted 
exposure, namely cataract and cancer induction. In general, dose values were low, and all dose 
values were well within the current US maximum allowable exposure of 5,000 mrem per year.  
The other categories of participants, including CRNA and RN, did not achieve 
significance for phase in part because they could not see the screen, which was optimally 
positioned for the operator. However, although other staff groups did not achieve significance, it 
is still important for staff members to wear their badges. The health team should work together to 
monitor the radiation screen and perhaps communicate effectively to lessen exposure.  
To remedy, the deficit of increased visualization for all team members, it is 
recommended that additional software, available in the past year, be included in the real-time 
dose monitoring system. The new software called Dose Aware Extend transfers data from the 
base station to an additional large LED screen displayed prominently in many operating rooms. 
Presence of the LED screen enhances communication, safety, and transparency in real time in 
any operating room. Many components of the patient’s care are conveyed on the screen, such as 
procedure, allergies, blood loss, and provider names. It is recommended that the RaySafe 
occupational exposure data be considered an essential piece of patient information included on 
this screen to enhance the safety of faculty and staff working in the room.  
 Educating all staff regarding the availability and necessity real-time dose monitoring is 
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also an important aspect of eliciting change. Robert Stevenson, MD, cardiologist and 
electrophysiologist, at Good Samaritan Hospital, Lebanon, Pennsylvania, stated, “There is 
always room for improvement and everyone from the physicians, staff to the administrators, 
share in that responsibility. The hospital is responsible to provide the latest technology to protect 
the staff and the day-to-day proper operation of the equipment and its ability to protect the staff 
is the responsibility primarily of the physician,” he explained.65 Miles Carver, director of 
Invasive Cardiology Services at Good Samaritan Hospital, Lebanon, Pennsylvania, further 
stated, “Education is the key to making lasting changes. You also need a champion radiation 
safety committee, and the committee needs to be very active.”65 It is recommended through 
education, real- time dose monitoring systems will be more prevalent in suites such as EPLs as 
well as other radiologic areas to optimize the occupational health and safety of all faculty and 
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Appendix 2: Consent Form University of Michigan IRB 
 
UNIVERSITY OF MICHIGAN 
CONSENT TO BE PART OF A RESEARCH STUDY 
 
 
Name of Study and Researchers  
 
Title of Project: Radiologic monitoring of faculty and staff in an Electrophysiology lab using a real time 
dose monitoring system  
Principal Investigator: Kathy Chardenet, CRNA, MSA 
Faculty Advisor: Dr. Milo Engoren MD 
Consultants: Dr. E. Christodoulou, PhD, Dr. Joann Prisciandaro PhD  
Co-Investigators: Dr. Anna Dubovoy MD, Dr. Shawn Fryzel DrAP  
 
GENERAL Information  
We are conducting research regarding radiologic monitoring of faculty and staff in an Electrophysiology 
lab using a real time dose monitoring system. The purpose of this study is to assess whether the use of a 
real time monitoring system will result in decreased individual and aggregate exposure among faculty 
and staff working in an electrophysiology lab (EP). To gather information, we are asking 150 participants, 
including EP Interventionists, EP fellows, EP RN’s, EP technicians, and nurse anesthetists to participate. 
This study will be conducted for 3 months in EP lab 3. 
 
If you agree to participate in this study, you will be asked to utilize radiation protective equipment as 
normally specified by your job duties. You should continue to wear the radiation monitoring dosimeters 
(Landau-radiation monitoring dosimeters), issued by the UM-OSEH/RSS as normal to meet the 
regulatory requirements. You should also use the mandatory protective aprons and thyroid shields 
required by the State's Michigan Dept. of Licensing and Regulatory Affairs (LARA), hospital policies, and 
OSEH/RSS. 
 
In addition to your normal radiation safety procedures, you will be asked to wear both a passive 
dosimeter and a real time dose monitor for all cases for the day you are assigned to an 
electrophysiology lab. You will not see the readings on the real-time monitor for the first half of this 
study (roughly 6 weeks), and you will be able to see the readings during the second half.  
  
Scatter levels for the real time dose monitor will be measured in aggregate for all participants and 
individually for Interventionist, Fellow and Anesthesia staff. Break times currently are not recorded for 
the technician and RN staff and therefore their individual levels cannot be determined. Individual 
cumulative total exposure from your passive dosimeter will continue to be monitored via our existing 
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Radiation Safety service. Although the PI or study team members may know the name and radiologic 
exposure of participants on any given day of the study, results from the study will be presented only in 
terms of trends or overall findings and will not include information about specific participants 
 
This project is deemed as no more than minimal risk. The study team does not foresee or anticipate any 
direct risk to the subjects. You may not receive any personal or direct benefit from being in this study. 
There may be an indirect benefit due to possible improvement of awareness to radiologic exposure to 
you as well as to other faculty and staff participating in cases that involve radiation. There will be no 
compensation for participating in the study. Unfors RaySafe, the manufacturer of the real time dose 
monitoring system, could profit from the results of the study. 
 
You will not be identified in any reports on this study. Records will be kept confidential to the extent 
provided by federal, state, and local law. However, the Institutional Review Board, the sponsor of the 
study, (University of Michigan Hospitals) or university and government officials responsible for 
monitoring this study may inspect these records.  
 
A video will also be provided at the time of consent for regarding the Real Time Dose monitoring system. 
Viewing the video is voluntary. The video was produced in conjunction with Phillips and the RaySafe 
Corporation, and can be found in advance at: 
https://www.youtube.com/watch?v=VdbgAVGPMIg 
 
Your participation in this project is voluntary. Even after you sign the informed consent document, you 
may decide to leave the study at any time without penalty or loss of benefits to which you may 
otherwise be entitled.  
 
If you have questions or concerns about this study or feel that the study has caused you any harm, 
Contact the study PI: 
Kathy Chardenet CRNA, MS, BBA 
Department of Anesthesiology,1H247 UH, SPC 5048  
1500 East Medical Center Drive,Ann Arbor, MI 48109-5048 
telephone 734-936-4270, page at 12240 
email: kpagels@umich.edu 
Additionally you may contact 
Dr. Milo Engoren engorenm@med.umich.edu or 734-470-6644,  
Dr. Anna Dubovoy aodnopoz@med.umich.edu or 734-647-2777 
Dr. E. Christodoulou Manos@med.umich.edu or 734-615-0120 
Dr. J. Prisciandaro Joannp@med.umich.edu or 734-936-6192 
or contact the hospital operator at 734-936-8000 and ask to have any of these individuals paged.  
  
If you have any questions or concerns about your rights as a research subject, or any grievance, you may 
also contact the Institutional Review Board for Human Subject Research (IRBMED), University of 









I understand the information printed on this form. I have discussed this study, its risks and potential 
benefits, and my other choices with Kathy Chardenet, Donna Carnahan or Ray Elmblad. My questions so 
far have been answered. I understand that if I have more questions or concerns about the study or my 
participation as a research subject, I may contact one of the people listed above. I understand that I will 
receive a copy of this form at the time I sign it and later upon request. I understand that if my ability to 
consent for myself changes, either I or my legal representative may be asked to re-consent prior to my 
continued participation in this study. 
 
Signature of Subject:     Date:  
 
Name (Print legal name):                     
 
Study ID:  Date of Birth:   
 
Principal Investigator (or Designee): 
 
I have given this research subject (or his/her legally authorized representative, if applicable) information 
about this study that I believe is accurate and complete. The subject has indicated that he or she 
understand the nature of the study and the risks and benefits of participating.  
 
Name:      
 
Title:      
 
Signature:      
 







Appendix 3: Figure 20: Recruitment form-University of Michigan IRB 
 
 
Dear Colleague,  
 
I ask for your participation at the University of Michigan Hospitals in a research study entitled, “Radiologic 
monitoring of faculty and staff in a electrophysiology lab using a real time dose monitoring system -
HUM00085102”.  
 
Currently, a passive dosimeter to measure scatter from radiation over a one month time period is utilized. A real 
time dose monitoring system represents another option for monitoring radiologic scatter and provides immediate and 
cumulative feedback to the participant during the case regarding their exposure. Participation in this study is 
voluntary. There is no direct benefit to you for participating, however, you may experience improvement in you 
awareness of radiologic exposure. The research question is, will the use of a real time monitoring system result in 
decreased individual and aggregate exposure among faculty and staff working in an electrophysiology lab (EP)? 
 
The study setting will involve EP lab 3 at the Cardiovascular Center. The real time dose monitoring system will be 
fixed to the gantry for the duration of the study.  
 
All participants in this 3-month quantitative cross over study will be asked to wear the radiation monitoring 
dosimeters (Landau-radiation monitoring dosimeters), issued by the UM-OSEH/RSS to meet the regulatory 
requirements. They should also use the mandatory protective aprons and thyroid shields required by the State's 
Michigan Dept. of Licensing and Regulatory Affairs (LARA), hospital policies, and OSEH/RSS. Radiation goggles 
and rolling shields are also suggested.  
 
 Scatter levels for the real time dose monitor will be measured in aggregate for all participants and individually for 
Interventionist, fellow and Anesthesia. This is due to break times currently are not recorded for the technician and 
RN therefore individual levels cannot be determined. Individual cumulative total for the passive dosimeter will 
continue to be determined per Radiation Safety. The PI or study team members may know the name and radiologic 
exposure of participants on any given day of the study. Results from the study will be presented only in terms of 
trends or overall findings and will not include information about specific participants.  
 
The eligible study population includes faculty and staff assigned to work in the EP lab for the study at the CVC 
Hospital, University of Michigan hospitals that work strictly with an adult population of patients. Eligible personnel 
population, ()=indicates total possible participants) includes the EP interventionist (10), cardiology fellow (10), 
nurse anesthetist (95), registered nurse (20) and technician (15). Exclusion criteria are people who do not work in EP 
with an adult population of patients or who decline to not be studied. 
 
A video will be provided at the time of consent for those who wish to view the technology and concept of a Real 
Time Dose Monitor. 
 
You need to give your written informed consent to participate. The date for the consenting process is ______, at 
_________locations at the time of _________. For questions regarding your rights as a participant in human 
subjects research, you may contact the University of Michigan Hospitals IRBMED (734) 763-4768 or Email: 
irbmed@umich.edu. 
 
If you have any questions regarding the purpose or procedures for this study, you may contact Kathy Chardenet, 
MSA, CRNA kpagels@umich.edu, or 734-936-4270 or pager 12240, Dr. Milo Engoren engorenm@med.umich.edu 
or 734-614-7679, Dr. Anna Dubovoy aodnopoz@med.umich.edu 734-936-9479, Dr. E. Christodoulou 
Manos@med.umich.edu or 734-615-0120, Dr. J. Prisciandaro Joannp@med.umich.edu or 734-936-6192 or call the 
hospital operator at 734-936-8000 and ask to have any of these individuals paged.  
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Kathy Chardenet, CRNA, MS 
DRAP student 
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